Prosecution Insights
Last updated: October 04, 2026

Cooley LLP

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

432 pending office actions • 268 clients • 366 examiners • 138 art units • 0 of 432 (0%) have an AI response strategy ready

Analysis

COOLEY LLP has a career history of 22191 applications, primarily in the Biotechnology & Pharmaceuticals technology area. The firm currently handles 355 pending office actions, which represents their active prosecution docket. This substantial volume of 22191 career applications provides a deep historical background for their work in Biotechnology & Pharmaceuticals. The 355 pending office actions show the firm's ongoing engagement with the patent office.

The resolved allowance rate for the firm is 78.5 percent, based on their 22191 career applications. This 78.5 percent rate is a key indicator of the firm's effectiveness in securing patent allowances. Prosecution involves an average of 3.53 office actions per allowance. This 3.53 average provides practitioners with a benchmark for the expected number of responses to reach a grant. With 355 pending office actions, the firm continues to apply its 78.5 percent allowance rate and 3.53 office action average. These metrics offer a comprehensive view of the firm's long-term performance and current workload.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=22191 apps, methodology: how we score firms)

78.5%
Allowance Rate
n=22191
+0.65σ
Allowance Rate (norm)
n=22191
3.5
OAs to Allowance
n=10299
-0.12σ
OAs to Allow (norm)
n=10299
1008 days
Time to Allowance
n=10299
+18.2pp
Interview Lift
n=22191
27.1%
RCE Rate
n=22191
1.1%
Appeal Rate
n=22191

Rejection Performance (% of received rejections ultimately overcome)

78.1%
§101 Overcome
n=1715
74.6%
§102 Overcome
n=4156
76.3%
§103 Overcome
n=6913
77.9%
§112 Overcome
n=5778

Specialization & Scale

A61K, A61P, C07K
Top CPC Subclasses
28%
Top-3 CPC Share
n=22191
165
Practitioners
n=22191
134.5
Apps / Practitioner
n=22191

Portfolio Summary

432
Total Pending OAs
303
Non-Final OAs
124
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 117 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

67
Overdue
3
Due this week
28
Due this month
15
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 117 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (67)Due ≤ 7 days (3)Due ≤ 30 days (28)Due ≤ 60 days (15)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

197
Hard (46%)
184
Medium (43%)
46
Easy (11%)
5
Unknown (1%)

Rejection Statute Mix

BucketCases
§101 only11 (3%)
§101 + other41 (9%)
§103 only89 (21%)
§102 only17 (4%)
§112 only31 (7%)
Double-patenting only15 (3%)
Double-patenting + other78 (18%)
Multi-statute (no §101)145 (34%)
No statute on record5 (1%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

193
Life Sciences
45% of docket
10
Information Tech
2% of docket
8
Communications
2% of docket
15
Semiconductors
3% of docket
102
Mechanical / Eng
24% of docket
104
Business / Other
24% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

4,320 h
Manual time on pending OAs
864 h
Time saved (low, 20%)
1,512 h
Time saved (mid, 35%)
37.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAGHIGHATIAN, MINA 3 46.1% +39.3%
COLEMAN, BRENDA LIBBY 3 74.9% +15.5%
WEDDINGTON, KEVIN E 3 75.2% +9.8%
TU, AURELIE H 3 56.4% +60.0%
HEASLEY, MEGHAN CHRISTINE 3 75.2% +34.0%
DEKARSKE, MADELINE MCGUIRE 3 0.0% +0.0%
RODRIGUEZ, RAYNA B 3 33.6% +19.2%
LIU, SUE XU 3 20.9% +18.6%
KIM, YUNSOO 3 65.9% +34.3%
MOU, LIYUAN 2 42.9% +59.0%

Hard Cases (203)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17944127 INTRA-AORTIC BALLOON PUMP ASSEMBLY GHAND, JENNIFER LEIGH-STEWAR 119d overdue
18021323 LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY HOPKINS, SAMANTHA LAKE 110d overdue
17491079 SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE CARDIAC MONITORING XU, JUSTIN 100d overdue
17019042 SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS DELLA, JAYMI E 100d overdue
19175765 BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING PATEL, OM 91d overdue
18407010 FLUID CONTROL DEVICES AND METHODS OF USING THE SAME TU, AURELIE H 85d overdue
17723112 CLEAN SCREEN CONTACTLESS ANALYTE DETECTION TEST GLOVER, NELSON ALEXANDER 84d overdue
17203464 CONNECTION QUALITY ASSESSMENT FOR EEG ELECTRODE ARRAYS PORTER, JR, GARY A 81d overdue

Interview Candidates (23)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18407010 FLUID CONTROL DEVICES AND METHODS OF USING THE SAME TU, AURELIE H 85d overdue
17083078 SYSTEMS AND METHODS FOR PROCESSING SONIFIED BRAIN SIGNALS TU, AURELIE H 79d overdue
17914308 BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS HAGHIGHATIAN, MINA 31d overdue
17802927 METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTS KIM, YUNSOO 18d overdue
18581000 NOVEL COMPOUNDS AND USES THEREOF COLEMAN, BRENDA LIBBY 5d
19431012 SALT FORMS OF R-MDMA AND METHODS USING THE SAME MOU, LIYUAN —
19016588 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS HAGHIGHATIAN, MINA —
18913906 SULFOXIMINE GLYCOSIDASE INHIBITORS COLEMAN, BRENDA LIBBY —

Client Portfolio (268 clients)

Client (Assignee)Pending OAs
Jazz Pharmaceuticals 11
24M Technologies 6
Magnolia Medical Technologies, Inc. 6
CeriBell, Inc. 6
Albireo 6
EMPATHBIO, INC. 5
Ancora Heart 5
RefleXion Medical, Inc. 5
Biolinq 5
Cellares 5
Epizyme 4
Terns Pharmaceuticals, Inc. 4
Portland Technology Holdings LLC 4
AgroSpheres 4
DroneUp, LLC 4
American Gene Technologies International 4
VDyne, Inc. 3
Terawave, Inc. 3
MindMed 3
Hyperspectral 3
Levita Magnetics International Corp. 3
Ibex Biosciences, Inc. 3
Altesa BioSciences, Inc. 3
ATAI Life Sciences 3
Surrozen Operating Inc. 3
Bellwether Coffee 3
Definium Therapeutics US, Inc. 3
Protego Biopharma, Inc. 3
Rein Therapeutics, Inc. 3
Erthos Inc. 3
Aptevo Therapeutics 3
GW RESEARCH LIMITED 3
Akeso Pharmaceuticals, Inc. 3
Canvas Pharmaceuticals 3
ROOBI TECHNOLOGIES CORPORATION 3
NuPulseCV, Inc. 3
Field Medical, Inc. 2
1st Avenue Nova 2
Spirair, Inc. 2
North American EP Technology LLC 2
Argenx 2
Casana Care 2
Orica International Pte Ltd 2
Welldoc, Inc. 2
Newronika S.p.A. 2
University of Cambridge 2
AiBUY 2
Gold Standard Radiation Detection 2
Intellective Ai, Inc. 2
Veir, Inc. 2
OXFORD UNIVERSITY INNOVATION LIMITED 2
Restora Medical, Inc. 2
Dstillery, Inc. 2
iCIMS, Inc. 2
Asceneuron SA 2
VILMORIN & CIE 2
Via Separations, Inc. 2
IKIN, Inc. 2
Aldeyra Therapeutics 2
Bayou Surgical 2
Kelvin Systems, Inc. 2
Mayo Clinic 2
Powercast Corporation 2
Clearside Biomedical 2
TOTUS MEDICINES INC. 2
Infinity Pharmaceuticals 2
Universitatsspital Basel 2
Natals, Inc. 2
Party IP Holdings LLC 2
REFEYN LTD 2
Amgen 2
Cooler Heads Care, Inc. 2
Native Microbials, Inc. 2
Cella Farms Inc. 2
Imel Biotherapeutics, Inc. 2
Invyxis 2
Sinkco Labs 2
Io Biotech Aps 2
American Solar Rail 2
University of Basel 2
PROVIVA THERAPEUTICS (HONG KONG) LIMITED 2
Unity Aluminum 2
Akeso Biopharma, Inc 2
Xzom 2
Atlas Data Storage, Inc. 2
BIOCON LIMITED 2
TES Pharma S.r.l. 2
C16 Biosciences 2
REMEGEN CO., LTD. 2
NanoXplore 2
Empatica 2
PEPTOMYC, S.L. 2
Allegro NV 1
Nyra Medical, Inc. 1
Astellas 1
EPIGENIC THERAPEUTICS PTE, LTD. 1
Prana Thoracic, Inc. 1
Fundación Para La Investigación Biomédica Del Hospital Infantil Universitario Niño Jesús 1
Therakos Development Limited 1
Domino Data Lab, Inc. 1
Emvolon, Inc. 1
Zenflow 1
CardioNXT, Inc. 1
Distalmotion 1
Panther Life Sciences Corporation 1
Metis Microsystems, LLC 1
Anodyne Chemistries 1
Alpfa Medical 1
Streetscope, Inc. 1
Mogam Institute 1
Osheru, Inc. 1
Biodrive, Inc. 1
Rivet Industries, Inc. 1
Alpenglow Biosciences, Inc. 1
Synapcis Inc. 1
Huntress Labs Incorporated 1
Attentive Mobile 1
Sondermind Inc. 1
Heartland Industries, Inc. 1
Sdip Innovations Pty Ltd. 1
Kernel Foods, Inc. 1
Uv-Concepts Inc. 1
Impello Biosciences, Inc. 1
Fred Hutchinson Cancer Research Center 1
Skate One Corp. 1
Brokkr Mineral Resources Corporation 1
Profusa, Inc. 1
Bendrx, Inc. 1
Collectors Universe 1
SAIC Motor 1
Atlas Data Storage 1
INVENTIVA 1
NysnoBio GT Neurology, LLC 1
Novocuff, Inc. 1
Empnia Inc. 1
Sinkco Labs PBC 1
Trevi Therapeutics, Inc. 1
Synergraze Inc. 1
Cyteir Therapeutics, Inc. 1
Inhabit Brands, Inc. 1
Gotchops Music Inc. 1
Pinnacle Biologics, Inc. 1
British Columbia Cancer Agency Branch 1
Stryd, Inc. 1
University Of Montréal 1
Nobell Foods, Inc. 1
Lumen Bioscience 1
Siren Care, Inc. 1
Prometheus Therapeutics Inc. 1
Otolith Sound Inc. 1
Ellodi Pharmaceuticals 1
Invalve Therapeutics, Inc. 1
Xenon Pharmaceuticals 1
Petal Surgical, Inc. 1
Retriever Medical, Inc. 1
MapLight Therapeutics, Inc. 1
Sonoclear AS 1
Curematch, Inc. 1
Biocontrol, LLC 1
EnteroMed Ltd 1
VALO HEALTH, INC. 1
Mojave Energy Systems, Inc. 1
Bach Diagnostics Inc. 1
Nomad Go, Inc. 1
Jasper Therapeutics, Inc. 1
CorFlow Therapeutics 1
BioXcel Therapeutics, Inc. 1
Grid.ai 1
CENTRO DE INMUNOLOGIA MOLECULAR 1
Crystal Jackson 1
Verkada Inc. 1
RedSea Science and Technology Inc. 1
American Gene Technologies International Inc. 1
Artizan Biosciences, Inc. 1
Rootz Research LLC 1
University of Michigan 1
Soricimed Biopharma Inc. 1
Ausperbio Therapeutics Inc. 1
DLF Seeds 1
VIROGIN BIOTECH CANADA LTD 1
Pandorum Technologies Private Limited 1
Jiangsu Xcmg State Key Laboratory Technology Co., Ltd. 1
IMMUNOFORGE CO., LTD. 1
Royston Anthony GRAY 1
Arthur AI, Inc. 1
Cyclopure, Inc. 1
Afyx Therapeutics A/S 1
Aquilo Sports LLC 1
Global Nutrient Conditioning LLC 1
Hanmi 1
Proniras Corporation 1
Pic Therapeutics, Inc. 1
AlphaOlympia LLC 1
HIBM Research Group 1
THE SCRIPPS RESEARCH INSTITUTE 1
Starling Medical, Inc. 1
TS Conductor Corp. 1
Liquiglide Inc. 1
UNC Chapel Hill 1
NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL 1
Rational Vaccines, Inc. 1
Ischemicure Ltd. 1
City of Hope 1
Maplight Ml-004, LLC 1
IMPACT THERAPEUTICS (SHANGHAI), INC 1
Microbion 1
DONG WOON ANATECH CO., LTD. 1
Usher III Initiative, Inc. 1
AMRYT PHARMACEUTICALS INC. 1
Summacor, Inc. 1
HotSpot Therapeutics 1
Soleno Therapeutics, Inc. 1
Dentity Partners, Inc. 1
Hertha Metals 1
Pep2Tango Therapeutics Inc. 1
American Gene Technologies International Inc. 1
Protaryx Medical Inc. 1
Ip21Po Innovations Limteed 1
Lava Therapeutics 1
ALLORION THERAPEUTICS INC 1
PICTOR LABS, INC. 1
Koya Medical 1
IVERIC bio 1
BrightPlan 1
Recorded Books, Inc. 1
Scout Bio, Inc. 1
FELDAN BIO 1
Tender Food, Inc. 1
Eisai 1
Grow More Foundation 1
Lyme Revive Foundation 1
Montana Molecular 1
Gemina Laboratories Ltd. 1
University of Chicago 1
BRII BIOSCIENCES, INC. 1
Pivot Bio, Inc. 1
Gliknik 1
I+D Device Solutions LLC 1
WAKE FOREST UNIVERSITY HEALTH SCIENCES 1
Forge Applied Science And Technology 1
4E Therapeutics 1
Nexus Agriscience, Inc. 1
Visura Technologies, Inc. 1
Deinde Medical 1
Aelan Cell Technologies, Inc. 1
UNIVERSITY OF MARYLAND, COLLEGE PARK 1
Teal Health, Inc. 1
Columbia University 1
University of Pennsylvania 1
Alzheon 1
KayoThera Inc. 1
THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO 1
Substrate Artificial Intelligence SA 1
Protagonist Therapeutics, Inc. 1
Certus Critical Care 1
Wesper Inc. 1
DaVinci Plastic Surgery, PC 1
University of Texas 1
Cttq-Akeso (Shanghai) Biomed. Tech. Co., Ltd. 1
Cornell University 1
EPFL 1
THE FRANCIS CRICK INSTITUTE LIMITED 1
Enara Bio 1
Scirhom GmbH 1
VivaLNK, Inc. 1
Takeda 1
Benchmark Labs, Inc. 1
Alleviant Medical 1

Top Art Units

Art UnitApps
379115
162811
379410
164110
37719
16279
37927
16437
37967
16267

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19538898 INJECTABLE HYDROGEL Allegro NV GOTFREDSON, GAREN 1619 §102§103§112Other Non-Final OA — Pending Feb 12, 2026
19445099 MULTI-SENSOR PATCH AND SIGNAL ANALYZER THAT ENABLE SAFE CARDIAC ABLATION Field Medical, Inc. VAHDAT, KHADIJEH A 3794 §103§112 Final Rejection — Pending Jan 09, 2026
19444133 TISSUE ABLATION CATHETER WITH AN INSULATOR BETWEEN INNER AND OUTER ELECTRODES Field Medical, Inc. OUYANG, BO 3794 §103 Final Rejection — Pending Jan 08, 2026
19431012 SALT FORMS OF R-MDMA AND METHODS USING THE SAME Empathbio, Inc. MOU, LIYUAN 1628 §103§112DP Final Rejection — Pending Dec 23, 2025
19429313 SYSTEMS, DEVICES, AND METHODS FOR REDUCING HEART VALVE REGURGITATION Nyra Medical, Inc. MANNAN, MIKAIL A 3774 §102§103§112Other Non-Final OA — Pending Dec 22, 2025
19420125 NATUREMOUNT SOLAR ARRAYS 1St Avenue Nova, LLC SUN, MICHAEL Y 1728 §102§103§112 Non-Final OA — Pending Dec 15, 2025
19413886 PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO THE EYE Astellas US LLC SHIN, DANA H 1635 §102§112DP Non-Final OA — Pending Dec 09, 2025
19409031 EPIGENETIC EDITING TOOL FOR TARGETING HEPATITIS B VIRUS GENE Epigenic Therapeutics Pte. Ltd. SHIN, DANA H 1635 §112Other Final Rejection — Pending Dec 04, 2025
19399418 SYSTEMS, DEVICES, AND METHODS FOR CONTROLLING ACTUATION OF TISSUE RESECTION DEVICES Prana Thoracic, Inc. RHODES, NORA W 3794 §103 Non-Final OA — Pending Nov 24, 2025
19393433 MINIMALLY INVASIVE NASAL TURBINATE SURGERY Spirair, Inc. HOLWERDA, KATHLEEN SONNETT 3771 §102§103 Final Rejection — Pending Nov 18, 2025
19392021 COMPOSITIONS AND METHODS FOR TREATING GENETIC DISORDERS Fundación Para La Investigación Biomédica Del Hospital Infantil Universitario Niño Jesús POPA, ILEANA 1633 §103 Final Rejection — Pending Nov 17, 2025
19383352 METHOD FOR GENERATING IMMUNOREGULATORY CELLS IN A BLOOD-DERIVED SAMPLE Therakos Development Limited HAMA, JOANNE 1647 §103DP Non-Final OA — Pending Nov 07, 2025
19379098 METHODS AND APPARATUS FOR IMPLEMENTING DATA ACCESS WITHIN A FILESYSTEM ACROSS CONTROL PLANES AND DATA PLANES Domino Data Lab, Inc. HAILU, TESHOME 2434 §103 Non-Final OA — Pending Nov 04, 2025
19374441 METHODS AND SYSTEMS FOR FACILITATING OXYGEN-ENRICHED PARTIAL OXIDATION REACTIONS TO CONVERT HYDROCARBONS INTO CARBON MONOXIDE AND HYDROGEN Emvolon, Inc. ANTHONY, JOSEPH DAVID 1764 §103§112 Non-Final OA — Pending Oct 30, 2025
19334242 METHODS FOR DEPLOYMENT OF AN IMPLANT Zenflow, Inc. GANESAN, SUBA 3774 §103 Non-Final OA 15d Pending Sep 19, 2025
19320650 ELECTROLYTE INCLUDING ELECTROLYTE SOLVENT, FLUOROETHER, AND BIS(FLUOROSULFONYL) SALT, AND LITHIUM METAL ELECTROCHEMICAL CELLS INCLUDING THE SAME 24M Technologies, Inc. CULLEN, SEAN P 1725 §102 Final Rejection 60d overdue Pending Sep 05, 2025
19305298 APPARATUS AND METHOD FOR MEASURING AND APPLYING HIGH VOLTAGE THROUGH A MATRIX OF WIRES AND CONDUCTIVE ELEMENTS Cardionxt, Inc. RHODES, NORA W 3794 §102§103 Non-Final OA 18d overdue Pending Aug 20, 2025
19300150 SYSTEMS, DEVICES, AND METHODS FOR HEALTH MONITORING VIA IMPLANTABLE DEVICES IN THE ANTERIOR MEDIASTINUM North American EP Technology LLC LOPEZ, SEVERO ANTON P 3791 §101§103DP Final Rejection — Pending Aug 14, 2025
19300138 SYSTEMS AND METHODS FOR DELIVERY OF A SUBSTERNAL LEAD OF AN IMPLANTABLE DEVICE North American EP Technology LLC LAUER, CHRISTINA C 3771 §103 Final Rejection — Pending Aug 14, 2025
19300364 SURGICAL ROBOTICS SYSTEMS AND DEVICES HAVING MODIFIED SPEED CONTROL NEAR WORKSPACE BOUNDARIES AND SURFACES, AND METHODS THEREOF Distalmotion SA MANCHO, RONNIE M §102 Non-Final OA — Pending Aug 14, 2025
19290146 MICRONEEDLE ARRAY SYSTEMS AND DEVICES, AND METHODS ASSOCIATED WITH MANUFACTURING AND USE Panther Life Sciences Corporation EPPERT, LUCY CLARE 3791 §103 Final Rejection 12d Pending Aug 04, 2025
19285497 CIRCUITS AND METHODS TO HARVEST ENERGY FROM TRANSIENT ON-CHIP DATA Metis Microsystems, LLC LAM, TUAN THIEU 2836 §101 Non-Final OA — Pending Jul 30, 2025
19275299 IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF HYDROGEN PEROXIDE Anodyne Chemistries, Inc. SAIDHA, TEKCHAND 1652 §102§112DP Final Rejection 10d overdue Pending Jul 21, 2025
19243836 SUBCUTANEOUS FCRN ANTAGONIST FORMULATIONS AND METHODS OF USE THEREOF Argenx BV SULLIVAN, DENNIS JOHN 1642 §103 Non-Final OA 28d Pending Jun 20, 2025
19234140 DEVICES, SYSTEMS, AND METHODS FOR MANIPULATING NASAL TISSUES Spirair, Inc. LOUIS, RICHARD G 3771 §103Other Non-Final OA — Pending Jun 10, 2025
19228396 SYSTEMS, DEVICES AND METHODS FOR HEALTH MONITORING AND IDENTIFICATION OF USERS Casana Care, Inc. BARR, MARY EVANGELINE 3683 §102§103 Non-Final OA — Pending Jun 04, 2025
19213905 APPARATUSES FOR PULSED ELECTRIC FIELD ABLATION THERAPY INCLUDING EXPANDABLE ELECTRODES, AND SYSTEMS AND METHODS THEREOF Alpfa Medical, Inc. HUPCZEY, JR, RONALD JAMES 3794 §102§103 Final Rejection — Pending May 20, 2025
19210844 APPARATUS AND METHOD FOR PROCESSING VEHICLE SIGNALS TO COMPUTE A BEHAVIORAL HAZARD MEASURE Streetscope, Inc. REDHEAD JR., ASHLEY L §102 Final Rejection — Pending May 16, 2025
19204207 WIRELESS INITIATION DEVICE Orica International Pte. Ltd. EGOAVIL, GUILLERMO J §112 Non-Final OA — Pending May 09, 2025
19196106 ANTIGEN VARIANT OF VARICELLA ZOSTER VIRUS AND USE THEREOF Mogam Institute For Biomedical Research DRISCOLL, LORA E BARNHART 3991 §103§112DP Non-Final OA — Pending May 01, 2025
19193799 DEVICES AND METHODS FOR TISSUE REMOVAL AND WOUND CLOSURE Osheru, Inc. LABRANCHE, BROOKE N §102§103 Non-Final OA — Pending Apr 29, 2025
19191923 TRANSCATHETER DELIVERABLE PROSTHETIC HEART VALVES AND METHODS OF DELIVERY VDyne, Inc. YABUT, DIANE D §102§103DP Non-Final OA — Pending Apr 28, 2025
19123383 Methods for Suppression of Gene Silencing in Plants Biodrive, Inc. KRUSE, DAVID H §102§103§112 Non-Final OA — Pending Apr 22, 2025
19181139 METHOD FOR EMBEDDING MESSAGE WAVEFORMS WITHIN CONVENTIONALLY MODULATED SIGNALS Terawave, Inc. SALTARELLI, DOMINIC D §102§103Other Non-Final OA — Pending Apr 16, 2025
19181114 SYSTEM AND METHOD FOR GENERATING A MULTI-COMPONENT SIGNAL INCLUDING A MODULATED SIGNAL AND AN AUXILIARY SIGNAL Terawave, Inc. KASSA, ZEWDU A §103 Non-Final OA — Pending Apr 16, 2025
19178636 METHODS AND APPARATUS FOR ESTIMATING DEPTH INFORMATION FROM THERMAL IMAGES Rivet Industries, Inc. SUMMERS, GEOFFREY E 2669 §112 Final Rejection 1d overdue Pending Apr 14, 2025
19177229 APPARATUSES, SYSTEMS, AND METHODS FOR PROCESSING OF THREE DIMENSIONAL OPTICAL MICROSCOPY IMAGE DATA Alpenglow Biosciences, Inc. RIDER, JUSTIN W 2486 §103 Non-Final OA — Pending Apr 11, 2025
19175765 BODILY-FLUID TRANSFER SYSTEM FOR BODILY FLUID SAMPLING Magnolia Medical Technologies, Inc. PATEL, OM 3791 §103§112 Non-Final OA 91d overdue Pending Apr 10, 2025
19171122 SYSTEM AND METHOD FOR AUTOMATIC ANALYSIS OF TEXTS IN PSYCHOTHERAPY, COUNSELING, AND OTHER MENTAL HEALTH MANAGEMENT ACTIVITIES Mind Medicine, Inc. LANE, DANIEL E 3715 §101§102§112 Non-Final OA — Pending Apr 04, 2025
19098339 METHOD FOR COMMUNICATION OVER TIME-BASED CHANNELS Terawave, Inc. PEREZ, JAMES M §112 Non-Final OA — Pending Apr 02, 2025
19098805 SYSTEMS AND METHODS FOR SEIZURE DETECTION Ceribell, Inc. MCCORMACK, ERIN KATHLEEN 3792 §101§103§112 Non-Final OA — Pending Apr 02, 2025
19088669 APPARATUS AND METHOD FOR A NEURAL INTERFACE UTILIZING SENSORY COMMUNICATION TO AFFECT A BROAD SPECTRUM OF PHYSIOLOGIC ACTIVITY IN THE HUMAN BODY Synapcis Inc. TRAN, JENNY NGAN §101§103§112 Non-Final OA — Pending Mar 24, 2025
19084221 SYSTEMS AND METHODS FOR ANALYZING, INTERPRETING, AND ACTING ON CONTINUOUS GLUCOSE MONITORING DATA Welldoc, Inc. BLOCH, MICHAEL RYAN DP Non-Final OA — Pending Mar 19, 2025
19080483 SYSTEMS AND METHODS FOR DETECTING FOODBORNE PATHOGENS USING SPECTRAL ANALYSIS Hyperspectral Corp. KIDWELL, KAITLYN ELIZABETH §101§103 Non-Final OA — Pending Mar 14, 2025
19076444 APPARATUS AND METHOD FOR CONDUCTING ENDPOINT-NETWORK-MONITORING Huntress Labs Incorporated GRACIA, GARY S §103 Non-Final OA — Pending Mar 11, 2025
19075437 METHODS AND APPARATUS FOR MOBILE DEVICE MESSAGING-BASED COMMUNICATIONS USING CUSTOM-GENERATED DEEPLINKS AND BASED ON THE HYPER TEXT TRANSFER PROTOCOL (HTTP) Attentive Mobile Inc. UBALE, GAUTAM 3689 §101§103Other Non-Final OA — Pending Mar 10, 2025
19069820 TWIN-CONFIGURABLE ARCHITECTURE RENEWABLE POWER PLANT FOR HIGH-CAPACITY FACTOR SERVICING OF CONTROLLABLE LOADS 1St Avenue Nova, LLC PEREZ BORROTO, ALFONSO 2836 §112Other Final Rejection 139d overdue Pending Mar 04, 2025
19069118 APPARATUS AND METHOD FOR TREATING NEUROLOGICAL DISORDERS Newronika S.p.A. ROANE, AARON F §101§102Other Non-Final OA — Pending Mar 03, 2025
19065984 ONE-OPERATOR SURGICAL SYSTEM AND METHODS OF USE Levita Magnetics International Corp. GHIMIRE, SHANKAR RAJ 3795 §102§103 Non-Final OA — Pending Feb 27, 2025
19061740 MODELING ANALYSIS OF TEAM BEHAVIOR AND COMMUNICATION Sondermind Inc. SHARMA, NEERAJ §102 Non-Final OA — Pending Feb 24, 2025
19055839 OPTICAL MICROSCOPY Cambridge Enterprise Limited COOK, JONATHON 2877 §103 Non-Final OA 36d Pending Feb 18, 2025
19104558 SYSTEM AND METHODS FOR PRODUCING FUNCTIONALIZED NATURAL FIBERS Heartland Industries, Inc. AHMED, SHEEBA §102§103 Non-Final OA — Pending Feb 18, 2025
19052537 MYOCARDIAL IMPLANT LOAD SHARING DEVICE AND METHODS TO PROMOTE LV FUNCTION Ancora Heart, Inc. SCHERBEL, TODD J DP Non-Final OA — Pending Feb 13, 2025
19048514 INTERACTIVE PRODUCT PLACEMENT SYSTEM AND METHOD THEREFOR AiBUY Holdco, Inc. KURIEN, CHRISTEN A 2421 §103 Non-Final OA 42d Pending Feb 07, 2025
19040645 BIORESORBABLE IMPLANT WITH INSIDE-OUT RESORPTION FOR ENHANCED BONE INGROWTH AND TISSUE INTEGRATION AND METHOD OF MANUFACTURING THEREOF Sdip Innovations Pty Ltd. COUGHLIN, DANIEL F §103 Non-Final OA — Pending Jan 29, 2025
19039151 AUTOMATED SYSTEMS AND APPARATUSES FOR STORING, TRANSPORTING, DISPENSING, AND TRACKING WIRELESS INITIATION DEVICE COMPONENTS CONFIGURABLE FOR INITIATING EXPLOSIVE MATERIAL COMPOSITIONS Orica International Pte. Ltd. ABDOSH, SAMIR 3641 §103 Non-Final OA — Pending Jan 28, 2025
19035521 FOOD DISPENSER Kernel Foods, Inc. WALCZAK, DAVID J §102§103 Non-Final OA — Pending Jan 23, 2025
19034292 BEAM STATION TREATMENT PLANNING AND RADIATION DELIVERY METHODS Reflexion Medical, Inc. LUONG, PETER 3797 §102§103§112 Non-Final OA — Pending Jan 22, 2025
19029849 MODULAR COMPONENTS, SYSTEMS, AND METHODS FOR DISINFECTING OBJECTS Uv-Concepts Inc. SPAMER, DONALD R §103Other Non-Final OA — Pending Jan 17, 2025
19023132 FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY Mind Medicine, Inc. HOERNER, PAUL ELLSWORTH §103§112 Non-Final OA — Pending Jan 15, 2025
19022958 COUNTER COUNTERFEIT AND EMBEDDED BARCODE TECHNOLOGY Gold Standard Radiation Detection, Inc. TOOHEY, RICHARD ORLANDO §103§112 Non-Final OA — Pending Jan 15, 2025
19018786 COGNITIVE INFORMATION SECURITY USING A BEHAVIOR RECOGNITION SYSTEM Intellective AI, Inc. GUNDRY, STEPHEN T §103 Non-Final OA — Pending Jan 13, 2025
19016588 METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS Impello Biosciences, Inc. HAGHIGHATIAN, MINA §102§103§112DP Non-Final OA — Pending Jan 10, 2025
19012630 SYSTEMS AND METHODS FOR COOLING OF SUPERCONDUCTING POWER TRANSMISSION LINES Veir, Inc. NORMAN, MARC E 3763 §102§103§112DP Non-Final OA — Pending Jan 07, 2025
19008094 HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY Fred Hutchinson Cancer Research Center COHEN, MICHAEL P §102§103§112DP Non-Final OA — Pending Jan 02, 2025
19005135 SKATEBOARD TRUCK Skate One Corp. JOHNS, HILARY LYNN DP Non-Final OA — Pending Dec 30, 2024
18982877 MATERIALS AND METHODS FOR RECOVERING METALS FROM ORE Brokkr Mineral Resources Corporation XU, QING 1656 §103 Non-Final OA 28d overdue Pending Dec 16, 2024
18979367 OPTICAL FILTER DEVICE, SYSTEM, AND METHODS FOR IMPROVED OPTICAL REJECTION OF HIGH ANGLE OF INCIDENCE (AOI) LIGHT Profusa, Inc. JUNG, JONATHAN Y 2871 §103§112 Non-Final OA — Pending Dec 12, 2024
18971420 INTERFEROMETRIC SCATTERING MICROSCOPY Oxford University Innovation Limited CHOUDHURY, MUSTAK §103Other Non-Final OA — Pending Dec 06, 2024
18967162 MANAGING OBSTRUCTIVE SLEEP APNEA THROUGH UPPER AIRWAY DUAL NEUROSTIMULATION Restora Medical, Inc. GEDEON, BRIAN T §102§103 Non-Final OA — Pending Dec 03, 2024
18869941 MACROCYCLIC OREXIN RECEPTOR AGONISTS AND USES THEREOF Jazz Pharmaceuticals Ireland Limited OTTON, ALICIA L §112 Non-Final OA — Pending Nov 27, 2024
18956891 SYSTEMS AND METHODS FOR BENDING A NEEDLE Bendrx, Inc. KIM, BOBBY YEONJIN 3725 §102 Final Rejection — Pending Nov 22, 2024
18949761 SYSTEMS AND METHODS FOR MACHINE LEARNING MODELING OF EMBEDDING SPACE MAPPING Dstillery, Inc. MACASIANO, MARILYN G 3622 §101 Non-Final OA — Pending Nov 15, 2024
18946732 LAPAROSCOPIC GRASPERS AND SYSTEMS THEREFOR Levita Magnetics International Corp. SHI, KATHERINE MENGLIN §102§103§112 Non-Final OA — Pending Nov 13, 2024
18942377 METHOD AND APPARATUS FOR EMISSION GUIDED RADIATION THERAPY Reflexion Medical, Inc. MALEVIC, DJURA §103 Non-Final OA — Pending Nov 08, 2024
18940070 INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR) Jazz Pharmaceuticals Therapeutics, Inc. DAVIS, BRIAN J §101§112 Non-Final OA — Pending Nov 07, 2024
18937709 ANTIBODIES AND THERAPEUTIC USES THEREOF Ibex Biosciences, Inc. FAUST, AMBER KATHLEEN 1643 §101DP Non-Final OA — Pending Nov 05, 2024
18934442 CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS Empathbio, Inc. JEAN-LOUIS, SAMIRA JM §102§112 Non-Final OA — Pending Nov 01, 2024
18933637 METHODS AND APPARATUS FOR GENERATING A COMPOUND PRESENTATION THAT EVALUATES USERS AND REFINING JOB LISTINGS USING MACHINE LEARNING BASED ON FIT SCORES OF USERS AND EXTRACTED IDENTIFIERS FROM JOB LISTINGS DATA Icims, Inc. YESILDAG, LAURA G 3629 §101 Final Rejection — Pending Oct 31, 2024
18931992 METHODS AND APPARATUS FOR GRADING IMAGES OF COLLECTABLES USING IMAGE SEGMENTATION AND IMAGE ANALYSIS Collectors Universe, Inc. AKHAVANNIK, HADI §103DP Non-Final OA — Pending Oct 30, 2024
18861107 PYROTECHNIC CHARGE CHAMBER, HYBRID GAS GENERATOR AND SAFETY AIRBAG Yanfeng International Automotive Technology Co., Ltd. SLITERIS, JOSELYNN Y 3614 §102§103§112 Non-Final OA — Pending Oct 28, 2024
18858085 CODECS FOR DNA DATA STORAGE Atlas Data Storage, Inc. BRADEN, GRACE VICTORIA 2112 §103 Final Rejection 30d overdue Pending Oct 18, 2024
18918569 STERILE BODILY-FLUID COLLECTION DEVICE AND METHODS Magnolia Medical Technologies, Inc. MELHUS, BENJAMIN S §102Other Non-Final OA — Pending Oct 17, 2024
18913906 SULFOXIMINE GLYCOSIDASE INHIBITORS Asceneuron SA COLEMAN, BRENDA LIBBY §112DP Non-Final OA — Pending Oct 11, 2024
18912442 USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY Jazz Pharmaceuticals Research UK Limited MCKOY, QUINCY ANDRE §103§112 Non-Final OA — Pending Oct 10, 2024
18907400 CUCURBITA WITH DETERMINATE GROWTH HABIT VILMORIN & CIE KUBELIK, ANNE R 1663 §102§112 Non-Final OA — Pending Oct 04, 2024
18907083 HEAT EXCHANGER INTEGRATION WITH MEMBRANE SYSTEM FOR EVAPORATOR PRE-CONCENTRATION Via Separations, Inc. SPIES, BRADLEY R §112DP Non-Final OA — Pending Oct 04, 2024
18907166 SYSTEM AND METHOD FOR PARALLEL DENOISING DIFFUSION Ikin, Inc. DRYDEN, EMMA ELIZABETH §102§103 Non-Final OA — Pending Oct 04, 2024
18854287 CRYSTALLINE FORM OF LANIFIBRANOR Inventiva KIFLE, BRUCK — Non-Final OA — Pending Oct 04, 2024
18904373 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT Aldeyra Therapeutics, Inc. OH, TAYLOR V §112 Non-Final OA — Pending Oct 02, 2024
18901912 GENE THERAPY DELIVERY OF PARKIN MUTANTS HAVING INCREASED ACTIVITY TO TREAT PARKINSON'S DISEASE NysnoBio GT Neurology, LLC GONZALES, JOSEPHINE MARIA 1631 §102§103DP Non-Final OA — Pending Sep 30, 2024
18900199 ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS Epizyme, Inc. GEMBEH, SHIRLEY V DP Non-Final OA — Pending Sep 27, 2024
18896264 BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS Albireo AB O DELL, DAVID K DP Non-Final OA — Pending Sep 25, 2024
18895046 METHOD FOR TREATING CANCER Epizyme, Inc. WEDDINGTON, KEVIN E §112Other Non-Final OA — Pending Sep 24, 2024
18849340 TRICYCLIC PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS Jazz Pharmaceuticals Ireland Limited BAUER, BRIANNA LEE §112 Non-Final OA — Pending Sep 20, 2024
18885519 CLEANING DEVICES AND SYSTEMS FOR SURGICAL INSTRUMENTS, AND METHODS THEREOF Bayou Surgical, Inc. JOYNER, KEVIN §102§103§112 Non-Final OA — Pending Sep 13, 2024
18882671 METHODS FOR USING CERVICAL CONTROL SYSTEMS AND CERVICAL CONTROL DEVICES Novocuff, Inc. BYRD, BRIGID K 3771 §102§103 Non-Final OA — Pending Sep 11, 2024
18882153 METHOD AND APPARATUS FOR REAL TIME RESPIRATORY GATING SIGNAL GENERATION AND DETECTION OF BODY DEFORMATION USING EMBEDDED FIBER BRAGG GRATINGS Empnia Inc. RAHLL, JERRY T §102§103§112 Non-Final OA — Pending Sep 11, 2024
18830480 DEVICES AND METHODS FOR THE MITIGATION OF NON-ANALYTE SIGNAL PERTURBATIONS INCIDENT UPON ANALYTE-SELECTIVE SENSOR Biolinq Incorporated KRETZER, KYLE W. §101§103 Non-Final OA — Pending Sep 10, 2024
18827122 SPOTLIGHT TRAINING OF LATENT MODELS USED IN VIDEO COMMUNICATION Ikin, Inc. TSWEI, YU-JANG 2614 §103§112 Non-Final OA 22d Pending Sep 06, 2024
18825531 DEEP SEA SUB-SEDIMENT SLURRY INJECTION FOR CARBON REMOVAL Sinkco Labs Pbc OLSON, LARS A 3615 §112 Final Rejection 32d overdue Pending Sep 05, 2024
18824317 FORMULATIONS OF PSILOCIN THAT HAVE ENHANCED STABILITY Mind Medicine, Inc. HOERNER, PAUL ELLSWORTH §103§112 Non-Final OA — Pending Sep 04, 2024
18824546 DUAL FUNCTION DOMESTIC HOT WATER PREHEATER AND INTEGRATED SPACE HEATER Kelvin Systems, Inc. OGG, DAVID EARL 2119 §101§102§103§112DP Non-Final OA — Pending Sep 04, 2024
18824121 TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA Trevi Therapeutics, Inc. BARSKY, JARED 1628 §103DP Non-Final OA 49d overdue Pending Sep 04, 2024
18821591 EXTENDED METABOLISM METHODS FOR INCREASING AND EXTRACTING METABOLITES FROM ALGAE AND MICROORGANISMS Synergraze Inc. HOLLAND, PAUL J §101§102§103DP Non-Final OA — Pending Aug 30, 2024
18818708 RAD51 INHIBITORS Cyteir Therapeutics, Inc. CREWS, JARET JAMES §101§102§112DP Non-Final OA — Pending Aug 29, 2024
18812593 SYSTEMS, DEVICES, AND METHODS FOR DISPENSING AND APPLYING SUBSTANCES Inhabit Brands, Inc. ZADEH, BOB 3754 §102§103§112 Non-Final OA — Pending Aug 22, 2024
18811236 DEVICES AND METHODS FOR TRANSVASCULAR DRAINAGE OF FLUIDS IN AN INTRACRANIAL EXTRAVASCULAR SPACE Mayo Foundation for Medical Education and Research MARCETICH, ADAM M §103 Non-Final OA — Pending Aug 21, 2024
18807699 SYSTEMS, DEVICES, AND METHODS FOR CONDITIONAL EXECUTION OF AUTOMATIC CELL PROCESSING Cellares Corporation ZHU, JIANJIAN 1631 §102§103§112DP Non-Final OA — Pending Aug 16, 2024
18807543 DEVICES AND METHODS FOR MEASURING MUSICAL INSTRUMENT STRINGS Gotchops Music Inc. SAUNDERS, ANNA JOSEPHINE §102§103 Non-Final OA — Pending Aug 16, 2024
18807294 PHOTODYNAMIC THERAPY COMPOSITIONS AND METHODS OF USE THEREOF Pinnacle Biologics, Inc. REILLY, SOPHIA JANE §102§103§112DP Non-Final OA — Pending Aug 16, 2024
18795069 METHODS, SYSTEMS, AND APPARATUS FOR AUTOMATIC RF POWER TRANSMISSION AND SINGLE ANTENNA ENERGY HARVESTING Powercast Corporation MILLER, BRANDON J 2647 §103Other Non-Final OA — Pending Aug 05, 2024
18791751 HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE British Columbia Cancer Agency Branch SHIAO, REI TSANG DP Non-Final OA — Pending Aug 01, 2024
18788602 TRAJECTORY CLUSTER MODEL FOR LEARNING TRAJECTORY PATTERNS IN VIDEO DATA Intellective AI, Inc. YANG, WEI WEN §103 Non-Final OA — Pending Jul 30, 2024
18787732 EXPENDITURE TO OVERCOME AIR RESISTANCE DURING BIPEDAL MOTION Stryd, Inc. MELHUS, BENJAMIN S §102Other Non-Final OA — Pending Jul 29, 2024
18787979 METHODS AND APPARATUS FOR ELECTRODE PLACEMENT AND TRACKING Ceribell, Inc. MINCHELLA, ADAM ZACHARY 3794 §102§103 Final Rejection 56d overdue Pending Jul 29, 2024
18786975 COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION Aldeyra Therapeutics, Inc. HUANG, GIGI GEORGIANA Other Non-Final OA — Pending Jul 29, 2024
18784566 METHOD AND SYSTEM FOR GENERATION AND PLAYBACK OF SUPPLEMENTED VIDEOS AiBUY Holdco, Inc. EKPO, NNENNA NGOZI 2425 §103 Non-Final OA — Pending Jul 25, 2024
18783755 SYSTEMS, DEVICES, AND METHODS FOR MONITORING LOADS AND FORCES ON A SEAT Casana Care, Inc. DOWNEY, JOHN R 3792 §103§112 Non-Final OA — Pending Jul 25, 2024
18781682 APPARATUS AND METHODS FOR MAINTAINING STERILITY OF A SPECIMEN CONTAINER Magnolia Medical Technologies, Inc. TU, AURELIE H 3791 DP Non-Final OA — Pending Jul 23, 2024
18779877 ANTICHOLINERGIC COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS University Of Montréal OH, TAYLOR V §102§112 Non-Final OA — Pending Jul 22, 2024
18779937 ARTIFICIAL INTELLIGENCE AND/OR MACHINE LEARNING MODELS TRAINED TO PREDICT USER ACTIONS BASED ON AN EMBEDDING OF NETWORK LOCATIONS Dstillery, Inc. ANSARI, AZAM A 3621 §101§103Other Non-Final OA — Pending Jul 22, 2024
18779458 FOOD COMPOSITIONS COMPRISING RECOMBINANT MILK PROTEINS Nobell Foods, Inc. O'HERN, BRENT T §103§112 Non-Final OA — Pending Jul 22, 2024
18778354 DEVICE FOR ADAPTIVE TREATMENT OF NEUROLOGICAL DISEASES AND METHOD FOR CONTROLLING A DEVICE FOR ADAPTIVE TREATMENT OF NEUROLOGICAL DISEASES Newronika S.p.A. KOWALKOWSKI, FIONA MARGARET 3792 §102 Non-Final OA — Pending Jul 19, 2024
18778225 Crystal Modifications of Odevixibat Albireo AB COLEMAN, BRENDA LIBBY §112DP Non-Final OA — Pending Jul 19, 2024
18773019 Asymmetric Battery Having a Semi-Solid Cathode and High Energy Density Anode 24M Technologies, Inc. FRASER, STEWART A 1724 Other Non-Final OA 126d overdue Pending Jul 15, 2024
18727976 METHOD OF ADMINISTERING OXYBATE Jazz Pharmaceuticals Ireland Limited WEDDINGTON, KEVIN E DPOther Non-Final OA — Pending Jul 10, 2024
18727926 NOVEL AMINE-SUBSTITUTED PHTHALAZINES AND DERIVATIVES AS SOS1 INHIBITORS Jazz Pharmaceuticals Ireland Limited SEAMAN, D MARGARET M §102§103§112 Non-Final OA — Pending Jul 10, 2024
18767011 TARGETED MUTAGENESIS IN SPIRULINA Lumen Bioscience, Inc. KONOPKA, CATHERINE ANNE 1635 §103 Final Rejection — Pending Jul 09, 2024
18767680 METHOD AND APPARATUS FOR DYNAMIC RF POWER SPLITTING THROUGH MANIPULATION OF DC OUTPUT PROPERTIES Powercast Corporation FIN, MICHAEL RUTLAND 2843 §102§103 Non-Final OA — Pending Jul 09, 2024
18766285 SENSOR ARRANGEMENTS FOR A SENSING GARMENT Siren Care, Inc. RAYAN, MIHIR K 2622 §103 Non-Final OA — Pending Jul 08, 2024
18764935 DEVICES AND METHODS FOR REPAIR OF A SELECTED BLOOD VESSEL OR PART THEREOF AND RAPID HEALING OF INJURED INTERNAL BODY CAVITY WALLS Prometheus Therapeutics Inc. WU, TONG E 3796 §112 Non-Final OA — Pending Jul 05, 2024
18726889 COMPOSITIONS AND METHODS FOR TREATING MACULAR EDEMA ASSOCIATED WITH UVEITIS Clearside Biomedical, Inc. PECKHAM, RICHARD GRANT §102§103§112DP Non-Final OA — Pending Jul 05, 2024
18763598 HYBRID LINEARIZATION SCHEME FOR X-RAY CT BEAM HARDENING CORRECTION Reflexion Medical, Inc. WELLS, HEATH E 2664 §103 Non-Final OA — Pending Jul 03, 2024
18763741 THERAPEUTIC CONJUGATES Totus Medicines Inc. CHANDRAKUMAR, NIZAL S 1625 DP Final Rejection 86d overdue Pending Jul 03, 2024
18763528 PROCESSES FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES Infinity Pharmaceuticals, Inc. NEAGU, IRINA §102DP Non-Final OA — Pending Jul 03, 2024
18760864 DEVICE FOR MITIGATING MOTION SICKNESS AND OTHER RESPONSES TO INCONSISTENT SENSORY INFORMATION Otolith Sound Inc. STUART, COLIN W §103§112DP Non-Final OA — Pending Jul 01, 2024
18755113 METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS Ellodi Pharmaceuticals, L.P. SCHMITT, MICHAEL J §103DP Non-Final OA — Pending Jun 26, 2024
18752629 HEART VALVE PROSTHESES AND RELATED METHODS Invalve Therapeutics, Inc. FLORES, ADRIAN §102§103 Non-Final OA — Pending Jun 24, 2024
18746981 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS Xenon Pharmaceuticals Inc. CARCANAGUE, DANIEL R 1621 §102Other Non-Final OA 196d overdue Pending Jun 18, 2024
18744469 SYSTEM AND METHOD FOR TISSUE INTERVENTION VIA IMAGE-GUIDED BOILING HISTOTRIPSY Petal Surgical, Inc. ROZANSKI, MICHAEL T 3797 §103 Non-Final OA 78d overdue Pending Jun 14, 2024
18744218 PRODRUGS OF MDMA, MDA, AND DERIVATIVES THEREOF Empathbio, Inc. SHTERENGARTS, SAMANTHA L §102§112 Non-Final OA — Pending Jun 14, 2024
18742879 MANAGING OBSTRUCTIVE SLEEP APNEA THROUGH AIRWAY NEUROSTIMULATION Restora Medical, Inc. MUTCHLER, CHRISTOPHER JOHN 3796 §103 Final Rejection 107d overdue Pending Jun 13, 2024
18737447 SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS Empathbio, Inc. FETTEROLF, BRANDON J §102 Non-Final OA — Pending Jun 07, 2024
18731095 SYSTEMS, DEVICES, AND METHODS FOR REAGENT STORAGE IN AUTOMATED CELL PROCESSING Cellares Corporation MCGUIRK, JOHN SCHUYLER 1798 §103 Final Rejection 31d overdue Pending May 31, 2024
18680305 Systems, Apparatus and Methods for Processing Autologous Blood for Reinfusion into a Patient Retriever Medical, Inc. MENON, KRISHNAN S DP Non-Final OA — Pending May 31, 2024
18712916 METHODS OF TREATING NEUROLOGICAL DISORDERS Maplight Therapeutics, Inc. ROCHELLE, CIERRA MARIE 1627 §103§112DP Non-Final OA — Pending May 23, 2024
18672122 METHOD OF TREATING HEPATITIS C VIRUS IN PATIENTS Altesa BioSciences, Inc. MILLER, DALE R §103 Non-Final OA — Pending May 23, 2024
18712472 ULTRASOUND COUPLING AGENT Sonoclear AS BAEK, JONGHWAN NMN §103DP Non-Final OA — Pending May 22, 2024
18712233 CLINICAL TRIAL OPTIMIZATION Curematch, Inc. NEWTON, CHAD A 3681 §101§102§103 Final Rejection — Pending May 21, 2024
18669430 SUSPENDED SUPERCONDUCTING TRANSMISSION LINES Veir, Inc. LEE, PETE T 2847 §103Other Non-Final OA — Pending May 20, 2024
18710338 INCREASED BIOLOGICAL AGENT PERFORMANCE AND REDUCED VARIATION ACROSS AREAS OF APPLICATION Biocontrol, LLC ARIANI, KADE 1651 §102§103§112 Non-Final OA — Pending May 15, 2024
18664239 DEVICES, SYSTEMS, AND METHODS FOR DELIVERING THERAPY TO A SACRAL NERVE Enteromed Ltd. JIAN, SHIRLEY XUEYING 3792 §102§103 Final Rejection 9d Pending May 14, 2024
18659197 R-MDMA and S-MDMA TO ASSIST PSYCHOTHERAPY Universitatsspital Basel NESTOR, DONNA MICHELLE 1627 §102§103§112DP Non-Final OA — Pending May 09, 2024
18656117 METHODS AND APPARATUS FOR ASSESSING DIVERSITY BIAS IN ALGORITHMIC MATCHING OF JOB CANDIDATES WITH JOB OPPORTUNITIES Icims, Inc. IQBAL, MUSTAFA 3625 §101§103 Non-Final OA — Pending May 06, 2024
18656137 RESISTANCE TO ToLCNDV IN SQUASH VILMORIN & CIE KUBELIK, ANNE R 1663 §101§112 Final Rejection 23d overdue Pending May 06, 2024
18654896 SKINCARE SUPPLEMENTS Natals, Inc. COUGHLIN, DANIEL F 1619 §103 Non-Final OA — Pending May 03, 2024
18706756 HISTONE DEACETYLASE 6 INHIBITOR COMPOUNDS AND USES THEREOF VALO HEALTH, INC. RAO, SAVITHA M 1691 §102§103§112 Non-Final OA — Pending May 02, 2024
18651843 TREATMENT OF LIVER DISORDERS WITH A THR-ß AGONIST Terns Pharmaceuticals, Inc. YOO, SUN JAE §103 Non-Final OA — Pending May 01, 2024
18541172 PRODRUGS OF DIMETHYLTRYPTAMINE AND DERIVATIVES THEREOF Atai Therapeutics, Inc. HEASLEY, MEGHAN CHRISTINE 1626 §102DP Non-Final OA — Pending May 01, 2024
18706071 CRYSTALLINE FORMS OF N-((1R,3S)-3-(4-ACETYLPIPERAZIN-1-YL)CYCLOHEXYL)-4-FLUORO-7-METHYL-1H-INDOLE-2-CARBOXAMIDE Epizyme, Inc. DEKARSKE, MADELINE MCGUIRE §103DP Non-Final OA — Pending Apr 30, 2024
18647212 ELECTRODIALYTIC LIQUID DESICCANT DEHUMIDIFYING SYSTEM Mojave Energy Systems, Inc. GITMAN, GABRIEL E 1772 §112Other Non-Final OA — Pending Apr 26, 2024
18641343 SYSTEMS AND METHODS FOR PET IMAGING ANALYSIS FOR BIOLOGY-GUIDED RADIOTHERAPY Reflexion Medical, Inc. KLEIN, BROOKE L 3797 §102§103§112 Non-Final OA — Pending Apr 20, 2024
18702376 LATERAL FLOW ASSAY FOR THE DIAGNOSIS OF DERMATOMYCOSIS Bach Diagnostics Inc. MARCSISIN, ELLEN JEAN §102§103§112 Non-Final OA — Pending Apr 18, 2024
18637516 METHODS AND APPARATUS FOR MACHINE LEARNING SYSTEM FOR EDGE COMPUTER VISION AND ACTIVE REALITY Nomad Go, Inc. GLASS, RUSSELL S 3627 §103Other Non-Final OA — Pending Apr 17, 2024
18638658 SYSTEMS, DEVICES, AND METHODS FOR AUTOMATED ANALYSIS OF FLUID SAMPLES FROM A CELL PROCESSING SYSTEM Cellares Corporation LE, AUSTIN Q 1796 §103§112 Final Rejection — Pending Apr 17, 2024
18702078 MODIFIED STEM CELL COMPOSITIONS AND METHODS FOR USE Jasper Therapeutics, Inc. FAUST, AMBER KATHLEEN §101§102§103§112Other Non-Final OA — Pending Apr 17, 2024
18634420 INTEROPERABILITY AND DATA EXCHANGE CAPABILITIES BETWEEN A BLOOD GLUCOSE MONITOR AND A CONTINUOUS GLUCOSE MONITOR Biolinq Incorporated TOMBERS, JOSEPH A 3791 §101§102§103 Non-Final OA 34d Pending Apr 12, 2024
18634528 SYSTEM AND METHODS FOR TREATING MVO Corflow Therapeutics AG HALL, DEANNA K 3783 §112DP Non-Final OA — Pending Apr 12, 2024
18634242 PREVENTION OR TREATMENT OF SLEEP DISORDERS USING DEXMEDETOMIDINE FORMULATION Bioxcel Therapeutics, Inc. RODRIGUEZ, RAYNA B §102§103 Non-Final OA — Pending Apr 12, 2024
18633118 SYSTEM AND METHOD FOR HETEROGENEOUS MODEL COMPOSITION Grid.Ai, Inc. MISIR, DAYWAYSHWAR D 2127 §101§103Other Non-Final OA 10d overdue Pending Apr 11, 2024
18630519 MONOCLONAL ANTIBODY AND A METHOD THEREOF Centro De Inmunologia Molecular SKELDING, ZACHARY S §112DP Non-Final OA — Pending Apr 09, 2024
18629151 COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF Terns Pharmaceuticals, Inc. JAIN, AVEESH 4100 §103Other Non-Final OA — Pending Apr 08, 2024
18626920 DIAGNOSTIC CATHETERS, GUIDE CATHETERS, VISUALIZATION DEVICES AND CHORD MANIPULATION DEVICES, AND RELATED KITS AND METHODS Ancora Heart, Inc. HALL, DEANNA K §103 Non-Final OA — Pending Apr 04, 2024
18698621 MONOCONAL ANTIBODIES TO IL-25 AND USES THEREOF Crystal Jackson DRISCOLL, MAUREEN VARINA §112DP Non-Final OA — Pending Apr 04, 2024
18625711 HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS Portland Technology Holdings Llc. MOREAU, NASHARA LOUISE 1655 §101§102§103Other Non-Final OA — Pending Apr 03, 2024
18624023 METHODS AND SYSTEMS FOR COMBINING IMAGES TO DETECT MOVING OBJECTS DEPICTED IN VIDEO CAMERA DATA Verkada Inc. ABDI, AMARA 2668 §103 Final Rejection 29d Pending Apr 01, 2024
18623001 STRAW EXTENSION FOR CAPPED CONTAINERS Party Ip Holdings LLC GORMAN, DARREN W 3752 §102§112 Non-Final OA — Pending Mar 31, 2024
18622057 COMPOUNDS AS GLP-1R AGONISTS Terns Pharmaceuticals, Inc. ROZOF, TIMOTHY R 1625 §102DP Non-Final OA — Pending Mar 29, 2024
18620826 SYSTEMS, DEVICES, AND METHODS FOR FLUID TRANSFER WITHIN AN AUTOMATED CELL PROCESSING SYSTEM Cellares Corporation SHRIEVES, STEPHANIE ALEXANDRA 3753 §103§112 Non-Final OA — Pending Mar 28, 2024
18618724 TOMATO VARIETIES DESIGNATED 'MX20-15', 'X21-09', 'X20-06', and 'X20-07' Redsea Science And Technology Inc. SULLIVAN, BRIAN JAMES 1663 §112DP Non-Final OA — Pending Mar 27, 2024
18615749 PRE-IMMUNIZATION AND IMMUNOTHERAPY American Gene Technologies International Inc. SALVOZA, M FRANCO G 1672 §103§112DP Non-Final OA — Pending Mar 25, 2024
18694627 SMALL MOLECULE INHIBITORS OF BACTERIAL TOXINS Artizan Biosciences, Inc. HEASLEY, MEGHAN CHRISTINE 1626 §102§103§112 Non-Final OA — Pending Mar 22, 2024
18612106 APPARATUS AND METHOD FOR ANALYZING REPETITIVE ACTIVITY Rootz Research LLC BROCKINGTON III, WILLIAM S §101 Non-Final OA — Pending Mar 21, 2024
18609391 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF The Regents of the University of Michigan LEWIS, PATRICK T 1691 §102Other Non-Final OA — Pending Mar 19, 2024
18605112 TRPV6 INHIBITORS AND COMBINATION THERAPIES FOR TREATING CANCERS Soricimed Biopharma Inc. SULLIVAN, DENNIS JOHN 1642 §103§112 Non-Final OA — Pending Mar 14, 2024
18604259 METHOD OF TREATING ENTEROVIRUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS Altesa BioSciences, Inc. SZNAIDMAN, MARCOS L 1628 §102§103 Non-Final OA — Pending Mar 13, 2024
18604264 METHOD OF DOSING VAPENDAVIR TO TREAT ENTEROVIRUS INFECTIONS Altesa BioSciences, Inc. PATEL, SAGAR S 1626 §102§103§112DP Non-Final OA — Pending Mar 13, 2024
18603039 VACCINES FOR CORONAVIRUS PREVENTION AND TREATMENT Ausperbio Therapeutics Inc. GILL, RACHEL B §103§112 Non-Final OA — Pending Mar 12, 2024
18597717 ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS Jazz Pharmaceuticals Research UK Limited CHANG, KYUNG SOOK 1613 §103§112Other Final Rejection 43d overdue Pending Mar 06, 2024
18597679 TISSUE-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF Surrozen Operating, Inc. YU, DELPHINUS DOU YI §112 Non-Final OA — Pending Mar 06, 2024
18594957 COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS AgroSpheres, Inc. FAN, LYNN Y 1759 §102§103DP Final Rejection 15d Pending Mar 04, 2024
18688167 METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE Dlf Seeds SPEED, DEQUANTARIUS JAVON 1663 §103§112 Non-Final OA 33d Pending Feb 29, 2024
18686229 ENGINEERED ONCOLYTIC HERPESVIRUSES VIROGIN BIOTECH CANADA LTD. JOHNSON, KARA D 1632 §102§103§112 Non-Final OA — Pending Feb 23, 2024
18584292 COMPRESSION SYSTEMS FOR ELECTROCHEMICAL CELLS AND ELECTROCHEMICAL CELL STACKS 24M Technologies, Inc. HO, ANDREW YEWHONG §102§103§112 Non-Final OA — Pending Feb 22, 2024
18441875 AUTOMATIC GRASPER ALIGNMENT SYSTEM FOR AN UNMANNED VEHICLE Droneup, LLC KIM, SANG K §103§112 Non-Final OA — Pending Feb 14, 2024
18441858 APPARATUS, SYSTEMS, AND METHODS TO GRASP AND RELEASE PACKAGES AT AN UNMANNED VEHICLE Droneup, LLC MOSCOSO, JUAN SALVADOR 3652 §102§103 Non-Final OA — Pending Feb 14, 2024
18437857 METHODS FOR CULTURING MESENCHYMAL STEM CELLS, COMPOSITIONS AND IMPLEMENTATIONS THEREOF Pandorum Technologies Private Limited SINGH, ANOOP KUMAR 1632 §103§112 Non-Final OA — Pending Feb 09, 2024
18294701 INTERFEROMETRIC SCATTERING MICROSCOPY Refeyn Ltd. PHILLIPS, RUFUS L 2877 §103 Final Rejection 43d overdue Pending Feb 02, 2024
18294699 GEARBOX FAULT DETECTION METHOD AND DEVICE Jiangsu Xcmg State Key Laboratory Technology Co., Ltd. LEE, BYUNG RO 2858 §101§103 Non-Final OA — Pending Feb 02, 2024
18429295 COFFEE ROASTING SYSTEM HAVING AN AGITATOR BLADE SET WITH A MINIMUM AIR GAP Bellwether Coffee Co. THONG, YEONG JUEN 1792 §102§103 Non-Final OA — Pending Jan 31, 2024
18429293 COFFEE ROASTING SYSTEM HAVING A REMOVABLE VESSEL WITH A RESIDUAL CHAFF CHAMBER AND RESIDUAL WATER CHAMBER Bellwether Coffee Co. WANG, FRANKLIN JEFFERSON 3761 §103§112 Non-Final OA 29d Pending Jan 31, 2024
18424585 MULTIBIOTIC SUPPLEMENTS Natals, Inc. ARMATO JR, DENNIS IGNATIUS 1651 §101§102§103§112 Non-Final OA — Pending Jan 26, 2024
18421264 R-MDMA FOR TREATMENT OF PAIN Definium Therapeutics US, Inc. ANDERSON, REBECCA L 1626 §102§103 Final Rejection 13d Pending Jan 24, 2024
18421886 ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE Immunoforge Co., Ltd. MARTINEZ, TARA L 1654 §103Other Non-Final OA 41d Pending Jan 24, 2024
18291294 STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE Amgen, Inc. BAKSHI, PANCHAM §112 Final Rejection — Pending Jan 23, 2024
18419081 TRANSTHYRETIN STABILIZING COMPOUNDS Protego Biopharma, Inc. KUCHARCZK, JED A 1623 §102DP Non-Final OA — Pending Jan 22, 2024
18581000 NOVEL COMPOUNDS AND USES THEREOF Royston Anthony Gray COLEMAN, BRENDA LIBBY 1624 §103§112 Non-Final OA 5d Pending Jan 19, 2024
18579572 METHOD OF DETERMINING THE IDENTITY OF A BIOMOLECULE Refeyn Ltd. RAHMAN, MD M 2877 §101 Non-Final OA — Pending Jan 16, 2024
18413512 MACHINE LEARNING MONITORING SYSTEMS AND METHODS Arthur AI, Inc. SMITH, BRIAN M §101§103§112DP Non-Final OA — Pending Jan 16, 2024
18412350 SYSTEMS, DEVICES, AND METHODS FOR SCHEDULING WORKFLOWS FOR AUTOMATED CELL THERAPY MANUFACTURING Cellares Corporation LIMBAUGH, KATHRYN ELIZABETH §102 Non-Final OA — Pending Jan 12, 2024
18410056 REGENERATION OF POLYMERIC CYCLODEXTRIN ADSORBENTS Cyclopure, Inc. NGUYEN, CAM N §102§103§112 Non-Final OA — Pending Jan 11, 2024
18407010 FLUID CONTROL DEVICES AND METHODS OF USING THE SAME Magnolia Medical Technologies, Inc. TU, AURELIE H 3791 §102§112 Final Rejection 85d overdue Pending Jan 08, 2024
18577028 EPITHELIAL SODIUM CHANNEL (ENAC) INHIBITOR CONJUGATES AND METHODS FOR USE THEREOF Rein Therapeutics, Inc. ESPINOSA, CLAUDIA EDILMA 1624 §103§112 Non-Final OA — Pending Jan 05, 2024
18406022 PHARMACEUTICAL COMPOSITION COMPRISING ELECTROHYDRODYNAMICALLY OBTAINED FIBRES, THE COMPOSITION HAVING IMPROVED RESIDENCE TIME ON THE APPLICATION SITE Afyx Therapeutics A/S AZPURU, CARLOS A 1617 §103 Non-Final OA — Pending Jan 05, 2024
18404507 COMPOSITIONS COMPRISING BIODEGRADABLE THERMOPLASTIC BLENDS WITH PLASTICIZERS AND THE METHOD OF PRODUCTION Erthos Inc. NERANGIS, VICKEY M §102§103§112DP Non-Final OA — Pending Jan 04, 2024
18404492 BIODEGRADABLE THERMOPLASTIC BLEND COMPOSITIONS WITH MODIFIED STARCH-INDUCED FORCE RECOVERY PROPERTIES AND METHODS OF PRODUCTION THEREOF Erthos Inc. HEINCER, LIAM J §102§103§112DP Non-Final OA — Pending Jan 04, 2024
18404500 BIODEGRADABLE THERMOPLASTIC BLEND COMPOSITIONS WITH ELASTOMER-INDUCED FORCE RECOVERY PROPERTIES AND THE METHODS OF PRODUCTION THEREOF Erthos Inc. PAK, HANNAH J §103§112Other Non-Final OA — Pending Jan 04, 2024
18401401 SALT FORMS OF R-MDMA AND METHODS USING THE SAME Empathbio, Inc. MOU, LIYUAN 1628 §102§103§112DP Non-Final OA — Pending Dec 30, 2023
18400948 UNMANNED VEHICLE PICK-UP AND DELIVERY SYSTEM WITH AUTOMATED ROBOTIC INTERNAL PACKAGE TRANSFER AND METHODS OF USE Droneup, LLC BROTHERS, LAURENCE RAPHAEL 3655 §103 Non-Final OA 16d Pending Dec 29, 2023
18401015 MULTIPRONGED END EFFECTOR OF ROBOTIC ARM IN AN UNMANNED VEHICLE PICK-UP AND DELIVERY SYSTEM FOR INTERNAL PACKAGE TRANSFER AND METHODS OF USE Droneup, LLC ADAMS, GREGORY W 3652 §103 Non-Final OA — Pending Dec 29, 2023
18396633 COOLING CAP ASSEMBLY AND COOLING UNIT Cooler Heads Care, Inc. AVIGAN, ADAM JOSEPH 3794 §102§103 Non-Final OA — Pending Dec 26, 2023
18394679 MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION Native Microbials, Inc. BERKE-SCHLESSEL, DAVID W 1651 §101Other Non-Final OA 40d Pending Dec 22, 2023
18394432 THERAPEUTIC PRESSURE, THERMAL, AND/OR OTHER TREATMENT MODALITY SYSTEMS AND METHODS Aquilo Sports LLC DAHER, KIRA B 3700 §102§103 Final Rejection — Pending Dec 22, 2023
18545423 LITTER CONDITIONER WITH MICROWAVE TECHNOLOGY AND METHOD OF USING THE SAME Global Nutrient Conditioning LLC LEE, CHEE-CHONG 3752 §103§112Other Non-Final OA — Pending Dec 19, 2023
18571114 MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF POST-ACUTE COVID-19 Rein Therapeutics, Inc. LIEB, JEANETTE M 1654 §103§112DP Non-Final OA — Pending Dec 15, 2023
18570861 MEDICAMENTS COMPRISING GLYCOSIDASE INHIBITORS Asceneuron SA ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103§112DPOther Final Rejection — Pending Dec 15, 2023
18540621 HIV PRE-IMMUNIZATION AND IMMUNOTHERAPY American Gene Technologies International Inc. KINSEY WHITE, NICOLE ERIN 1672 DP Non-Final OA — Pending Dec 14, 2023
18251827 PHARMACEUTICAL COMPOSITION FOR TREATING LEUKEMIA COMPRISING FLT3 INHIBITOR Hanmi Pharm. Co., Ltd. WEDDINGTON, KEVIN E 1629 §102§103DP Final Rejection 13d Pending Dec 12, 2023
18534255 THERMAL MASS INTEGRATION FOR HEAT PUMP Kelvin Systems, Inc. VAZQUEZ, ANA M 3763 §102§103 Non-Final OA — Pending Dec 08, 2023
18566735 METHODS OF TREATING NERVE AGENT-INDUCED SEIZURES Proniras Corporation LEE, CHIHYI NMN 1628 §103§112 Non-Final OA — Pending Dec 04, 2023
18517390 EIF4E INHIBITORS AND USES THEREOF Pic Therapeutics, Inc. SHI, GENBIN 1628 §103DP Non-Final OA — Pending Nov 22, 2023
18563440 ANTIBODIES Oxford University Innovation Limited LIU, SUE XU §102§103§112DP Non-Final OA — Pending Nov 22, 2023
18517543 METHODS OF USING PROTEIN INGREDIENTS TO MAKE DOUGHS, BAKED PRODUCTS, SOUPS, BEVERAGES, AND SNACKS Cella Farms Inc. CHAWLA, JYOTI 1791 §103 Non-Final OA — Pending Nov 22, 2023
18562949 ASSESSING AND TREATING OBESITY Mayo Foundation for Medical Education and Research HELLMAN, KRISTINA M 1654 §101§102§112 Non-Final OA — Pending Nov 21, 2023
18562701 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SKIN DISORDERS AND METHODS OF MANUFACTURE AND USE THEREOF AlphaOlympia LLC FIEBIG, RUSSELL G 1655 §101§103 Non-Final OA 26d Pending Nov 20, 2023
18562815 METHODS AND COMPOSITIONS FOR GENERATING MITOCHONDRIA REPLACED LYMPHOID CELLS Imel Biotherapeutics, Inc. KIM, TAEYOON §103§112 Non-Final OA — Pending Nov 20, 2023
18562816 METHODS AND COMPOSITIONS FOR REDUCING IMMUNE CELL EXHAUSTION USING MITOCHONDRIA REPLACEMENT Imel Biotherapeutics, Inc. HAMA, JOANNE §103DP Non-Final OA — Pending Nov 20, 2023
18562725 DOSING REGIMENS FOR PROTEIN THERAPEUTICS Aptevo Research and Development LLC STOICA, ELLY GERALD §102§112DP Non-Final OA — Pending Nov 20, 2023
18514227 MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY Hibm Research Group, Inc. WEHBE, ANNE MARIE SABRINA 1634 §103Other Final Rejection 18d overdue Pending Nov 20, 2023
18560337 DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY Jazz Pharmaceuticals Research UK Limited FOWLER, ALAN JEROME 1691 §102§103 Non-Final OA — Pending Nov 10, 2023
18560346 RESORCINOL DERIVATIVE AS A PHARMACEUTICALLY ACTIVE COMPOUND AND METHOD OF PREPARATION THEREOF Gw Research Limited FOWLER, ALAN JEROME 1691 §103Other Non-Final OA — Pending Nov 10, 2023
18504724 HETEROARYL DIAMIDE IRE1/XBP1s ACTIVATORS The Scripps Research Institute ROBINSON, MIKHAIL O'DONNEL 1627 §102 Non-Final OA 26d overdue Pending Nov 08, 2023
18504056 SYSTEMS, DEVICES, AND METHODS FOR EVENT-BASED KNOWLEDGE REASONING SYSTEMS USING ACTIVE AND PASSIVE SENSORS FOR PATIENT MONITORING AND FEEDBACK Atai Therapeutics, Inc. BURGESS, JOSEPH D 3685 §102§103 Final Rejection 30d overdue Pending Nov 07, 2023
18501402 Treating Alagille Syndrome (ALGS) Albireo AB PALENIK, JEFFREY T 1615 §103DP Non-Final OA — Pending Nov 03, 2023
18498752 BODILY FLUID MANAGEMENT SYSTEM Starling Medical, Inc. MARCETICH, ADAM M 3781 §101§103§112Other Final Rejection — Pending Oct 31, 2023
18385203 COMBINATION THERAPIES Infinity Pharmaceuticals, Inc. PIHONAK, SARAH 1627 §102§103DP Non-Final OA — Pending Oct 30, 2023
18494596 Spirocycle Containing Bicyclic Heteroaryl Compounds Protego Biopharma, Inc. ANDERSON, REBECCA L 1626 §102§112 Non-Final OA — Pending Oct 25, 2023
18383630 CARRIER AND FILLER FOOD COMPOSITIONS WITH HIGH PROTEIN AND LOW LIPID CONTENT Cella Farms Inc. LEBLANC, KATHERINE DEGUIRE 1791 §103§112 Non-Final OA — Pending Oct 25, 2023
18494601 Spirocycle Containing Pyridine Compounds Protego Biopharma, Inc. KOSAR, ANDREW D 1625 §112DP Non-Final OA — Pending Oct 25, 2023
18383308 SMART COMPOSITE CONDUCTORS AND METHODS OF MAKING THE SAME Ts Conductor Corp. PATEL, AMOL H 2847 §103 Non-Final OA — Pending Oct 24, 2023
18556632 COMPOSITIONS AND METHODS FOR IMPROVING MILK YIELD AND MILK COMPOSITIONAL CHARACTERISTICS IN RUMINANTS Native Microbials, Inc. CRUM, MARY ABOU NADER 1613 §101§102§103§112DP Non-Final OA — Pending Oct 20, 2023
18490732 HIGH BANDWIDTH BINARY MULTI-LEAF COLLIMATOR DESIGN Reflexion Medical, Inc. LANNU, JOSHUA DARYL DEANON §103§112 Non-Final OA — Pending Oct 19, 2023
18380830 HEAT TRANSFER PLATES IN ELECTROCHEMICAL CELL SYSTEMS, AND METHODS OF PRODUCING THE SAME 24M Technologies, Inc. HOWELL, MARC C 1774 §102§103 Non-Final OA 15d Pending Oct 17, 2023
18487811 ACETAL, KETAL, AND HEMIAMINAL ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE Invyxis, Inc. SEITZ, ANTHONY JOSEPH 1629 §103 Final Rejection — Pending Oct 16, 2023
18487841 ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE Invyxis, Inc. BREDEFELD, RACHAEL EVA 3786 §103 Final Rejection 22d Pending Oct 16, 2023
18378806 SYSTEMS AND METHODS FOR CREATING DURABLE LUBRICIOUS SURFACES VIA INTERFACIAL MODIFICATION Liquiglide Inc. BUTCHER, ROBERT T 1764 §102§103Other Non-Final OA — Pending Oct 11, 2023
18483823 COMPOSITIONS AND METHODS FOR LONG-TERM CARBON STORAGE IN THE DEEP SEA USING A FREE FALL PENETRATOR Sinkco Labs FIORELLO, BENJAMIN F 3678 §103§112 Final Rejection — Pending Oct 10, 2023
18375905 LITHIUM BATTERIES UTILIZING NANOPOROUS SEPARATOR LAYERS 24M Technologies, Inc. CREPEAU, JONATHAN 1725 §103§112 Non-Final OA — Pending Oct 02, 2023
18479702 INTRAOPERATIVE ENDOSCOPE CLEANING SYSTEM Bayou Surgical, Inc. ZAMORY, JUSTIN L 3783 §103 Non-Final OA — Pending Oct 02, 2023
18553312 METHODS FOR ASSESSING PROLIFERATION AND ANTI-FOLATE THERAPEUTIC RESPONSE The University of North Carolina at Chapel Hill VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §101§103§112DP Non-Final OA — Pending Sep 29, 2023
18284782 METHODS OF TREATMENT USING PROTEIN BINDERS TO IRHOM2 EPITOPES New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital for Special MACFARLANE, STACEY NEE 1675 §102§112 Non-Final OA — Pending Sep 28, 2023
18284793 MUTANT HERPESVIRUS AND VACCINE COMPOSITIONS Rational Vaccines, Inc. ALLEN, MICHAEL D 1671 §101§112 Non-Final OA — Pending Sep 28, 2023
18475929 DEVICES, SYSTEMS AND METHODS TO REMOVE BLOOD CLOTS Ischemicure Ltd. RODJOM, KATHERINE MARIE 3771 §102§103Other Final Rejection — Pending Sep 27, 2023
18284413 CAR T CELL THERAPY AND IFN GAMMA City Of Hope LEE, YIE CHIA 1642 §103§112 Final Rejection 9d Pending Sep 27, 2023
18552420 PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN Maplight Ml-004, LLC SASAN, ARADHANA 1615 §103DP Final Rejection — Pending Sep 25, 2023
18552434 ORAL CAPSULE OF PARP INHIBITOR AND PREPARATION METHOD THEREOF Impact Therapeutics (Shanghai), Inc. BASQUILL, SEAN M 1614 §103§112 Final Rejection 5d overdue Pending Sep 25, 2023
17914308 BISMUTH THIOL COMPOUNDS AND COMPOSITIONS AND METHODS OF TREATING MICROBIAL CO-INFECTIONS Microbion Corporation HAGHIGHATIAN, MINA 1616 §112DP Final Rejection 31d overdue Pending Sep 23, 2023
18471734 CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME Epizyme, Inc. BASQUILL, SEAN M 1614 §103 Non-Final OA — Pending Sep 21, 2023
18550878 THERAPEUTIC CONJUGATES Totus Medicines Inc. ELENISTE, PIERRE PAUL 1622 §102§112 Non-Final OA — Pending Sep 15, 2023
18550854 COMBINATION THERAPY FOR CANCER Io Biotech Aps JOHANSEN, PETER N. 1644 §102§103DP Non-Final OA — Pending Sep 15, 2023
18550440 BLOOD GLUCOSE PREDICTION SYSTEM AND METHOD BASED ON ARTIFICIAL INTELLIGENCE DONG WOON ANATECH CO., LTD. MACCAGNO, PIERRE L 3687 §101§103 Non-Final OA — Pending Sep 13, 2023
18466051 METHODS OF TREATING OR PREVENTING A PROTEOPATHY Usher III Initiative, Inc. JAVANMARD, SAHAR 1622 §112 Final Rejection 35d overdue Pending Sep 13, 2023
18243623 HEALTH-RELATED SIGNALING VIA WEARABLE ITEMS Biolinq Incorporated VASSELL, MEREDITH ABBOTT 1687 §112DP Final Rejection 85d overdue Pending Sep 07, 2023
18462120 HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS Atai Therapeutics, Inc. PATEL, SAGAR S 1626 §102 Non-Final OA 14d Pending Sep 06, 2023
18461874 RAIL TRANSPORTATION SYSTEM American Solar Rail, LLC MESHAKA, MAXWELL L 3615 §102§103§112 Non-Final OA 61d Pending Sep 06, 2023
18280329 COMPOSITIONS FOR THE TREATMENT OF EBV ASSOCIATED DISEASES OR CONDITIONS UNIVERSITÄT BASEL ALAM, DANYAL HASSAN 1672 §103§112 Non-Final OA 63d Pending Sep 05, 2023
18548650 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns Pharmaceuticals, Inc. WHITE, DAWANNA SHAR-DAY 1627 DP Final Rejection 26d Pending Sep 01, 2023
18548798 METHODS FOR TREATING FAMILIAL CHYLOMICRONEMIA SYNDROME Amryt Pharmaceuticals Inc. MCANANY, JOHN D 1625 §102§103§112 Final Rejection 18d overdue Pending Sep 01, 2023
18459308 LINEAR CARDIAC ASSIST PULSATILE PUMP Summacor, Inc. WEHRHEIM, LINDSEY GAIL 3799 §102§103 Non-Final OA — Pending Aug 31, 2023
18459142 IL-15 PROCYTOKINE ANTIBODY FUSION PROTEINS Proviva Therapeutics (Hong Kong) Limited GUSTILO, ESTELLA M 1646 §112 Non-Final OA — Pending Aug 31, 2023
18238270 Al-Mn-Zr BASED ALLOYS FOR HIGH TEMPERATURE APPLICATIONS Nanoal LLC ROE, JESSEE RANDALL 1759 §103 Final Rejection — Pending Aug 25, 2023
18455767 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. PIHONAK, SARAH 1627 §112 Final Rejection 22d Pending Aug 25, 2023
18547931 BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE Rein Therapeutics, Inc. MCCOLLUM, ANDREA K 1674 §101§102§112 Non-Final OA — Pending Aug 25, 2023
18454595 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF Soleno Therapeutics, Inc. SIMMONS, CHRIS E DP Non-Final OA — Pending Aug 23, 2023
18448855 APPARATUS AND METHOD FOR IDENTITY VERIFICATION IN A COMPUTER NETWORK WITH MULTIPLE ENTERPRISE PARTICIPANTS Dentity Partners, Inc. BECHTEL, KEVIN M 2400 §102 Final Rejection — Pending Aug 11, 2023
18546254 USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY Jazz Pharmaceuticals Research UK Limited BAUER, BRIANNA LEE 1623 §102§103§112Other Non-Final OA 20d Pending Aug 11, 2023
18264138 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-TIGIT ANTIBODY AND ANTI-PD-1/ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF Akeso Biopharma, Inc. CUNNINGCHEN, KATHLEEN MARY 1646 §103DP Non-Final OA — Pending Aug 03, 2023
18264191 THERAPEUTIC COMBINATION AND USE THEREOF Akeso Pharmaceuticals, Inc. DRISCOLL, LORA E BARNHART 3991 §103Other Final Rejection 28d overdue Pending Aug 03, 2023
18264242 PHARMACEUTICAL COMPOSITION AND USE THEREOF Akeso Biopharma, Inc. SHUPE, ELIZABETH A 1643 §103§112 Non-Final OA — Pending Aug 03, 2023
18363793 COMPOSITIONS AND METHODS COMPRISING HEMP EXTRACT FOR THE TREATMENT OF ANIMALS IN NEED Portland Technology Holdings LLC MELLER, MICHAEL V 1655 §102§103 Final Rejection 13d Pending Aug 02, 2023
18228923 SERIES FORMATION OF ELECTROCHEMICAL CELLS 24M Technologies, Inc. WEST, ROBERT GENE 1721 §102§103 Non-Final OA — Pending Aug 01, 2023
18227954 MICROWAVE POPCORN MAKER WITH HEATING INSERT Party Ip Holdings LLC KERR, ELIZABETH M 3761 §103 Final Rejection — Pending Jul 30, 2023
18227775 ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES American Gene Technologies International Inc. PRONZATI, GINA 1633 §112 Final Rejection 81d overdue Pending Jul 28, 2023
18358798 SYSTEMS AND METHODS FOR DETECTING PARTICLES OF INTEREST USING SPECTRAL ANALYSIS Hyperspectral Corp. MARINI, MATTHEW G 2853 §103 Final Rejection 2d overdue Pending Jul 25, 2023
18357040 METHOD AND APPARATUS FOR METALS, ALLOYS, MATTES, OR ENRICHED AND CLEANED SLAGS PRODUCTION FROM PREDOMINANTLY OXIDE FEEDS Hertha Metals, Inc. MCGUTHRY BANKS, TIMA MICHELE 1733 §102§103§112 Non-Final OA — Pending Jul 21, 2023
18352077 COMPOSITIONS INCLUDING MULTI-AGONIST PEPTIDES AND METHODS OF MANUFACTURE AND USE Pep2Tango Therapeutics Inc. LEE, JIA-HAI 1658 §103 Final Rejection — Pending Jul 13, 2023
18350589 ANTI-LRP5/6 ANTIBODIES AND METHODS OF USE Surrozen Operating, Inc. WEIDNER, ADAM M 1675 §112 Non-Final OA — Pending Jul 11, 2023
18261090 METHODS AND SYSTEMS FOR DETECTION AND DISCOVERY OF BIOMARKERS Xzom, Inc. MUI, CHRISTINE T 1797 §101§102§103§112 Final Rejection 34d Pending Jul 11, 2023
18271632 ENGINEERED NK CELLS AND METHODS OF TREATING CANCER American Gene Technologies International Inc. BRISTOL, LYNN ANNE 1643 §102§103§112 Non-Final OA — Pending Jul 10, 2023
18348553 APPARATUS AND METHOD FOR SEPTAL PUNCH AND DELIVERY AND MANEUVERING OF THERAPEUTIC DEVICE Protaryx Medical Inc. TANNER, JOCELIN C 3771 §103 Final Rejection 88d overdue Pending Jul 07, 2023
18347233 BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS Albireo AB DEKARSKE, MADELINE MCGUIRE 1622 §103Other Final Rejection — Pending Jul 05, 2023
18347295 ANTIBODIES TARGETED TO CD147 Ibex Biosciences, Inc. DENT, ALANA HARRIS 1643 §112 Final Rejection 28d overdue Pending Jul 05, 2023
18346749 SYSTEMS AND METHODS FOR DETECTING FOODBORNE PATHOGENS BY ANALYZING SPECTRAL DATA Hyperspectral Corp. PULLIAM, JOSEPH CONSTANTINE §101§103 Non-Final OA — Pending Jul 03, 2023
18345869 HEATED NANOWELLS FOR POLYNUCLEOTIDE SYNTHESIS Atlas Data Storage, Inc. BOYER, RANDY §103§112 Non-Final OA — Pending Jun 30, 2023
18344584 METHODS OF MANUFACTURE OF R-MDMA Definium Therapeutics US, Inc. DEKARSKE, MADELINE MCGUIRE 1622 §102 Non-Final OA 12d Pending Jun 29, 2023
18257995 COMPOSITIONS AND METHODS FOR CONTROLLING FUNGI AgroSpheres, Inc. LIU, SUE XU 1616 §102§103§112DPOther Non-Final OA — Pending Jun 16, 2023
18335542 USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6 BIOCON LIMITED GEORGE, DENNIS CHERIAN 1644 §103§112DP Final Rejection — Pending Jun 15, 2023
18209327 SYSTEMS AND METHODS FOR PARENTERALLY PROCURING BODILY-FLUID SAMPLES WITH REDUCED CONTAMINATION Magnolia Medical Technologies, Inc. FERNANDES, PATRICK M 3791 §103§112 Final Rejection 73d overdue Pending Jun 13, 2023
18207996 TREATING HEPATITIS Albireo AB SZNAIDMAN, MARCOS L 1628 §102§103Other Non-Final OA 53d Pending Jun 09, 2023
18266571 NOVEL COMPOUNDS Ip21Po Innovations Limteed LIEB, JEANETTE M 1654 DP Non-Final OA — Pending Jun 09, 2023
18332165 ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS Lava Therapeutics N.V. KIM, YUNSOO 1641 §101DP Non-Final OA — Pending Jun 09, 2023
18330903 ANTIBODIES TO HUMAN COMPLEMENT FACTOR C2b AND METHODS OF USE Argenx BV HADDAD, MAHER M 1641 §103Other Non-Final OA 58d overdue Pending Jun 07, 2023
18254573 AMINOHETEROARYL KINASE INHIBITORS Allorion Therapeutics Inc. PECKHAM, RICHARD GRANT 1627 §103 Final Rejection 33d Pending May 25, 2023
18201674 PYRIMIDINONE COMPOUNDS FOR TREATING ACUTE INFLAMMATION Tes Pharma S.r.l. RODRIGUEZ, RAYNA B 1628 §103§112 Final Rejection — Pending May 24, 2023
18199675 FORMULATIONS OF ANTIBODY BIOCON LIMITED KIM, YUNSOO 1641 §112Other Final Rejection — Pending May 19, 2023
18319843 METHOD OF GENERATING INFERENCE-BASED VIRTUALLY STAINED IMAGE ANNOTATIONS Pictor Labs, Inc. PROVIDENCE, VINCENT ALEXANDER 2617 §103 Final Rejection 132d overdue Pending May 18, 2023
18037262 BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES AgroSpheres, Inc. PAK, JOHN D 1699 §103DP Final Rejection — Pending May 16, 2023
18035594 EDIBLE MICROBIAL OIL C16 Biosciences, Inc. ZILBERING, ASSAF 1792 §102§103 Non-Final OA 34d Pending May 05, 2023
18312837 COMPRESSION GARMENT Koya Medical, Inc. SIPPEL, RACHEL T 3785 §103§112 Final Rejection — Pending May 05, 2023
18034821 METHODS FOR TREATING OPHTHALMOLOGICAL CONDITIONS Iveric Bio, Inc. LIPPOLIS, ALEXANDRA ROSE 1637 §103 Final Rejection 50d overdue Pending May 01, 2023
18309733 Goal Achievement Systems, Methods and Media Brightplan LLC LIU, I JUNG 3695 §101 Final Rejection 71d overdue Pending Apr 28, 2023
18140051 METHOD AND APPARATUS FOR AUDIO CONTENT CREATION VIA A COMBINATION OF A TEXT-TO-SPEECH MODEL AND HUMAN NARRATION Recorded Books, Inc. PATEL, SHREYANS A 2659 §103 Non-Final OA — Pending Apr 27, 2023
18250726 METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN Remegen Co., Ltd. STONEBRAKER, ALYSSA RAE 1642 §102§112Other Final Rejection — Pending Apr 26, 2023
18138375 SUBCUTANEOUS ADMINISTRATION OF AN ASBT INHIBITOR Albireo AB BARSKY, JARED 1628 §103DP Non-Final OA 33d Pending Apr 24, 2023
18033279 METHOD OF SUPPRESSING IMMUNE RESPONSE TO VECTOR-DELIVERED THERAPEUTIC PROTEIN Scout Bio, Inc. GROOMS, TIFFANY NICOLE 1637 §102§103§112 Non-Final OA — Pending Apr 21, 2023
18032329 PEPTIDE-BASED TRANSDUCTION OF NON-ANIONIC POLYNUCLEOTIDE ANALOGS FOR GENE EXPRESSION MODULATION Feldan Bio Inc. VANHORN, ABIGAIL LOUISE 1636 §103§112DP Final Rejection 7d Pending Apr 17, 2023
18296751 COOLING CAP ASSEMBLY AND COOLING UNIT Cooler Heads Care, Inc. AVIGAN, ADAM JOSEPH 3794 §103§112DP Non-Final OA — Pending Apr 06, 2023
18126756 PLANT-BASED SHREDDED MEAT PRODUCTS, AND METHODS OF PRODUCING THE SAME Tender Food, Inc. BECKER, DREW E 1792 §103§112Other Non-Final OA — Pending Mar 27, 2023
18188716 EZH2 INHIBITORS FOR TREATING LYMPHOMA Eisai R&D Management Co., Ltd. SIMMONS, CHRIS E 1622 §103Other Non-Final OA 42d Pending Mar 23, 2023
18182936 GENE EDITING MOLECULAR CLONING KITS Grow More Foundation CHATTERJEE, JAYANTA 1662 §103 Non-Final OA 46d overdue Pending Mar 13, 2023
18120797 MINERAL CATION COMPLEX COMPOSITIONS, FORMULATIONS THEROF, AND METHODS OF USE THEROF Lyme Revive Foundation NGUYEN, JOHN P 1619 §103 Final Rejection — Pending Mar 13, 2023
18120514 LARGE SCALE SYNTHESIS OF PHARMACEUTICAL AND BIOLOGIC FORMULATIONS USING THIN FILM FREEZING Canvas Pharmaceuticals, Inc. OSWALD, KIRSTIN U 3763 §103§112 Non-Final OA — Pending Mar 13, 2023
18182030 PROTEASE BIOSENSORS AND METHODS OF VIRUS DETECTION Montana Molecular LLC ALLEN, MICHAEL D 1671 §103 Final Rejection 46d overdue Pending Mar 10, 2023
18181325 DUAL-AFFINITY PROBES AND SYSTEMS FOR ANALYTE DETECTION Gemina Laboratories Ltd. NGUYEN, NAM P 1678 §102§112DP Non-Final OA — Pending Mar 09, 2023
18178703 MDMA TREATMENT TO ENHANCE ACUTE EMOTIONAL EFFECTS PROFILE OF LSD, PSILOCYBIN OR OTHER PSYCHEDELICS Universitatsspital Basel COPPINS, JANET L 1628 Other Final Rejection 41d Pending Mar 06, 2023
18117722 APPARATUS FOR CHARACTERIZATION OF GRAPHENE OXIDE COATINGS Via Separations, Inc. AKANBI, ISIAKA O 2877 §103 Final Rejection 11d overdue Pending Mar 06, 2023
18024471 ANTI-CD47 MONOCLONAL ANTIBODY AND USE THEREOF Akeso Pharmaceuticals, Inc. AEDER, SEAN E 1642 §103§112Other Final Rejection — Pending Mar 02, 2023
18176567 Long-LifeTime, Short Pulse, High Current Ion Source and Particle Accelerator Gold Standard Radiation Detection, Inc. LOGIE, MICHAEL J 2881 §102§103§112 Final Rejection 26d overdue Pending Mar 01, 2023
18022004 MODIFIED SERINE PROTEASE PROPROTEINS The University of Chicago ARMATO JR, DENNIS IGNATIUS 1651 §103 Non-Final OA 15d overdue Pending Feb 17, 2023
18041948 PHARMACEUTICAL COMPOSITION CONTAINING NEUROACTIVE STEROID AND USE THEREOF Brii Biosciences, Inc. LIU, SUE XU 1616 §102§103§112DP Non-Final OA — Pending Feb 16, 2023
18021323 LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY UNIVERSITÄT BASEL HOPKINS, SAMANTHA LAKE 1641 §102§112Other Final Rejection 110d overdue Pending Feb 14, 2023
18109408 METHODS OF EXFOLIATING AND DISPERSING A GRAPHITIC MATERIAL INTO POLYMER MATRICES USING SUPERCRITICAL FLUIDS Nanoxplore Inc. WASHVILLE, JEFFREY D 1766 §102§103 Non-Final OA — Pending Feb 14, 2023
18020040 IMPROVED PLANT NITROGEN CONSISTENCY THROUGH THE SUPPLY OF WHOLE PLANT NITROGEN FROM A NITROGEN FIXING MICROBE Pivot Bio, Inc. WILLIAMS, KEITH RICHARD 1663 §103§112 Non-Final OA — Pending Feb 06, 2023
18162308 FUSION PROTEINS OF HUMAN PROTEIN FRAGMENTS TO CREATE ORDERLY MULTIMERIZED IMMUNOGLOBULIN FC COMPOSITIONS WITH ENHANCED FC RECEPTOR BINDING Gliknik Inc. DAHLE, CHUN WU 1641 §103 Non-Final OA 8d Pending Jan 31, 2023
18101454 ANTI-MICROBIAL TUBING PROTECTION SYSTEM I+D Device Solutions LLC LAN, YAN 1782 §102§103 Non-Final OA 46d Pending Jan 25, 2023
18157759 CALIBRATION OF SOLID-STATE SENSORS Wake Forest University Health Sciences DO, AN H 2853 §101§102 Non-Final OA — Pending Jan 20, 2023
18153986 SYSTEMS AND METHODS FOR DETECTION OF DELIRIUM AND OTHER NEUROLOGICAL CONDITIONS Ceribell, Inc. BERHANU, ETSUB D 3791 §101 Non-Final OA 51d overdue Pending Jan 12, 2023
18094195 CLIPPING ACTUATOR Roobi Technologies Corporation CROSBY JR, RICHARD D 3724 §102§103 Non-Final OA 29d Pending Jan 06, 2023
18004659 MODIFICATION OF METALLIC SURFACES WITH PHOSPHONIC ACIDS Xzom, Inc. JACKSON, MONIQUE R 1787 §103 Final Rejection 79d overdue Pending Jan 06, 2023
18014701 INTERFEROMETRIC SCATTERING CORRELATION (ISCORR) MICROSCOPY Cambridge Enterprise Limited AMARA, MOHAMED K 2877 §103 Non-Final OA 71d overdue Pending Jan 05, 2023
18092701 METHODS, SYSTEMS, AND APPARATUSES FOR DISINFECTING AND SANITIZING MATERIALS Forge Applied Science And Technology YOO, REGINA M 1758 §112 Non-Final OA — Pending Jan 03, 2023
18003829 PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE 4E Therapeutics, Inc. HEASLEY, MEGHAN CHRISTINE 1626 §102§103DP Non-Final OA — Pending Dec 29, 2022
18084462 BREEDING WITH CANNABIS VARIETIES Nexus Agriscience, Inc. ABRAHAM, AMJAD A 1663 DP Non-Final OA — Pending Dec 19, 2022
18082963 COMPOSITIONS COMPRISING VORICONAZOLE INHALATION POWDER AND METHODS OF MANUFACTURE AND USE THEREOF Canvas Pharmaceuticals, Inc. RAO, SAVITHA M 1691 §102§103§112 Final Rejection — Pending Dec 16, 2022
18009682 CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS Amgen, Inc. RODRIGUEZ, RAYNA B 1628 §103Other Final Rejection — Pending Dec 09, 2022
18073877 APPARATUS, SYSTEMS AND METHODS FOR PROPER TRANSESOPHAGEAL ECHOCARDIOGRAPHY PROBE POSITIONING BY USING CAMERA FOR ULTRASOUND IMAGING Visura Technologies, Inc. MOHAMMED, SHAHDEEP 3797 §103§112Other Final Rejection — Pending Dec 02, 2022
17991238 RAIL TRANSPORTATION SYSTEM American Solar Rail, LLC MESHAKA, MAXWELL L 3614 §103 Final Rejection — Pending Nov 21, 2022
18056481 HEAD STABILIZATION SYSTEMS AND METHODS Deinde Medical Corp. ALBERS, KEVIN S 3786 §103§112 Non-Final OA — Pending Nov 17, 2022
17926069 COMPOSITIONS AND METHODS FOR FUNGAL INHIBITION USING MINICELL-BASED RNAi AgroSpheres, Inc. YU, DAVID TUYANG 1635 §102§103§112 Non-Final OA — Pending Nov 17, 2022
17988502 GRAPHENE-PATCHED YOLK-SHELL ANODES AND METHODS OF PRODUCING THE SAME Nanoxplore Inc. KENLAW, GRACE A 1723 §103§112 Non-Final OA — Pending Nov 16, 2022
18054427 H1.0K180ME2 ANTIBODIES, METHODS OF MAKING AND USES THEREOF Aelan Cell Technologies, Inc. DUTT, ADITI 1675 §112 Non-Final OA — Pending Nov 10, 2022
18052094 SYSTEMS AND METHODS FOR SCORE BASED CLUSTERS Welldoc, Inc. PATEL, JAY M 3681 §101§112 Non-Final OA — Pending Nov 02, 2022
17979580 HIGH STRENGTH AND THERMALLY STABLE 5000-SERIES ALUMINUM ALLOYS Nanoal LLC ROE, JESSEE RANDALL 1759 §103 Non-Final OA — Pending Nov 02, 2022
17975985 CIRCULAR METHODS FOR MANUFACTURING PRODUCTS FROM ALGAL BIOMASS AND ATMOSPHERIC CARBON REMOVAL WITH LONG-LIVED STORAGE USING ALGAE RESIDUAL BIOMASS USING PACKING AND SPREADED SINKAGE Sinkco Labs BOWERS, ERIN M 1653 §103§112 Non-Final OA — Pending Oct 28, 2022
17967293 METHODS AND SYSTEMS FOR NON-INVASIVE FORECASTING, DETECTION AND MONITORING OF VIRAL INFECTIONS Empatica Srl HOUGH, JESSANDRA F 3796 §101 Non-Final OA 16d overdue Pending Oct 17, 2022
17938234 NUCLEIC ACID BASED DATA STORAGE Atlas Data Storage, Inc. LU, FRANK WEI MIN 1683 §112 Final Rejection — Pending Oct 05, 2022
17944591 LAYER-BY-LAYER ASSEMBLY OF GRAPHENE OXIDE MEMBRANES VIA ELECTROSTATIC INTERACTION AND ELUDICATION OF WATER AND SOLUTE TRANSPORT MECHANISMS UNIVERSITY OF MARYLAND, BALTIMORE MCCULLOUGH, ERIC J. 1773 §112 Non-Final OA — Pending Sep 14, 2022
17944125 BLOOD PUMP SUPPORT APPARATUS AND METHOD FOR A BLOOD PUMP ASSEMBLY NuPulseCV, Inc. GHAND, JENNIFER LEIGH-STEWAR 3796 §102§103§112 Non-Final OA — Pending Sep 13, 2022
17944130 INTRA-AORTIC BALLOON PUMP ASSEMBLY WITH PRESSURE SENSOR NuPulseCV, Inc. HUH, VYNN V 3792 §102§103§112 Non-Final OA 21d Pending Sep 13, 2022
17944127 INTRA-AORTIC BALLOON PUMP ASSEMBLY NuPulseCV, Inc. GHAND, JENNIFER LEIGH-STEWAR 3796 §103§112 Non-Final OA 119d overdue Pending Sep 13, 2022
17929115 DEVICES, SYSTEMS, AND METHODS FOR SELF-COLLECTION OF BIOLOGICAL SAMPLES Teal Health, Inc. KREMER, MATTHEW 3791 §102§103§112 Non-Final OA 77d Pending Sep 01, 2022
17908509 ON DEMAND EXPRESSION OF EXOGENOUS FACTORS IN LYMPHOCYTES TO TREAT HIV American Gene Technologies International Inc. PRONZATI, GINA 1633 §112 Final Rejection — Pending Aug 31, 2022
17898882 APPARATUS AND METHODS TO PROVIDE A SCALABLE AND FLEXIBLE HIGH CHANNEL DENSITY NEURAL INTERFACE The Trustees of Columbia University in the City of New York MALAMUD, DEBORAH LESLIE 3792 §102§103 Final Rejection 15d Pending Aug 30, 2022
17802920 FORMULATIONS FOR PROTEIN THERAPEUTICS Aptevo Research and Development LLC HAM, JIEUN 1643 §102§103§112DP Non-Final OA — Pending Aug 26, 2022
17802927 METHODS AND COMPOSITIONS FOR PREVENTING ADSORPTION OF THERAPEUTIC PROTEINS TO DRUG DELIVERY SYSTEM COMPONENTS Aptevo Research and Development LLC KIM, YUNSOO 1641 §103§112 Final Rejection 18d overdue Pending Aug 26, 2022
17887326 CLIPPER Roobi Technologies Corporation MATTHEWS, JENNIFER S 3724 §103§112 Final Rejection — Pending Aug 12, 2022
17885280 MICROBIALLY PRODUCED PALM OIL SUBSTITUTES C16 Biosciences, Inc. HAWKINS, AMANDA SALATA 1793 §103 Non-Final OA — Pending Aug 10, 2022
17818854 METHODS OF INCREASING RESPONSE TO CANCER RADIATION THERAPY The Trustees of the University of Pennsylvania GUSTILO, ESTELLA M 1646 §103Other Non-Final OA 93d overdue Pending Aug 10, 2022
17877380 METHODS FOR TREATING NEUROLOGICAL DISORDERS Alzheon, Inc. MARTINEZ, TARA L 1654 §103DP Final Rejection 105d overdue Pending Jul 29, 2022
17795047 HETEROCYCLIC COMPOUNDS AND USES THEREOF Kayothera Inc. HASTINGS, ALISON AZAR 1627 §102§112DPOther Final Rejection 52d overdue Pending Jul 25, 2022
17871339 CROSSLINKED PARTICLES The Governing Council of the University of Toronto PARK, HAEJIN S 1614 DP Final Rejection 31d overdue Pending Jul 22, 2022
17869493 SYSTEMS AND METHODS FOR EFFICIENTLY IMPLEMENTING HIERARCHIAL STATES IN MACHINE LEARNING MODELS USING REINFORCEMENT LEARNING Substrate Artificial Intelligence SA CHEN, KUANG FU 2143 §102§103§112 Final Rejection — Pending Jul 20, 2022
17792594 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES Protagonist Therapeutics, Inc. DABKOWSKI, ERINNE R 1658 §103§112DP Non-Final OA — Pending Jul 13, 2022
17850832 TISSUE-PENETRATING ELECTROCHEMICAL SENSOR FEATURING A CO-ELECTRODEPOSITED THIN FILM COMPRISED OF POLYMER AND BIO-RECOGNITION ELEMENT Biolinq Incorporated CHUNG, HOSUNG CHARLES 1794 §102§103§112DP Non-Final OA — Pending Jun 27, 2022
17848731 NAIL CLIPPER WITH SAFETY FEATURES Roobi Technologies Corporation DO, NHAT CHIEU Q 3724 §103§112 Final Rejection 79d overdue Pending Jun 24, 2022
17786949 ORAL CANNABINOID FORMULATIONS Jazz Pharmaceuticals Research UK Limited ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §101§103Other Final Rejection 22d overdue Pending Jun 17, 2022
17842729 DEVICES, SYSTEMS, AND METHODS FOR FLUID DELIVERY Certus Critical Care, Inc. HOLLM, JONATHAN ADAM 3771 §103 Final Rejection 33d Pending Jun 16, 2022
17840933 SYSTEM AND METHODS FOR SENSOR-BASED DETECTION OF SLEEP CHARACTERISTICS AND GENERATING ANIMATION DEPICTION OF THE SAME Wesper Inc. MCCORMACK, ERIN KATHLEEN 3791 §102§103§112 Non-Final OA 7d Pending Jun 15, 2022
17836969 ADJUSTABLE GEOMETRY WEARABLE ELECTRODES Ceribell, Inc. MINCHELLA, ADAM ZACHARY 3794 §103§112 Non-Final OA 28d Pending Jun 09, 2022
17825551 DELIVERY AND RETRIEVAL DEVICES AND METHODS FOR SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES VDyne, Inc. IGBOKO, CHIMA U 3771 §112 Final Rejection — Pending May 26, 2022
17751177 SIDE-DELIVERABLE TRANSCATHETER PROSTHETIC VALVES AND METHODS FOR DELIVERING AND ANCHORING THE SAME VDyne, Inc. GANESAN, SUBA 3774 §102 Non-Final OA — Pending May 23, 2022
17743739 WEARABLE BIOSENSING DEVICE Empatica Srl MARLEN, TAMMIE K 3796 §102§103§112 Final Rejection — Pending May 13, 2022
17742945 ONCE DAILY FORMULATIONS OF TACROLIMUS Canvas Pharmaceuticals, Inc. HAGHIGHATIAN, MINA 1616 §103 Non-Final OA — Pending May 12, 2022
17734098 METHOD OF TITRATING DOSE OF PSYCHEDELICS Definium Therapeutics US, Inc. HEITMEIER, KENDALL NICOLE 1621 §102§103§112 Final Rejection — Pending May 01, 2022
17661122 HEMP EXTRACT AND METHODS OF USE THEREOF Portland Technology Holdings LLC MELLER, MICHAEL V 1655 §103DP Non-Final OA — Pending Apr 28, 2022
17723112 CLEAN SCREEN CONTACTLESS ANALYTE DETECTION TEST Davinci Plastic Surgery, Pc GLOVER, NELSON ALEXANDER 3791 §102§112 Final Rejection 84d overdue Pending Apr 18, 2022
17701294 ROBOTIC SURGERY SYSTEMS, DEVICES, AND METHODS OF USE Levita Magnetics International Corp. CHRISTIANSON, SKYLAR LINDSEY 3792 §103 Final Rejection — Pending Mar 22, 2022
17672346 FCRN ANTAGONISTS AND METHODS OF USE The Board Of Regents Of The University Of Texas System DAHLE, CHUN WU 1641 Other Final Rejection — Pending Feb 15, 2022
17591239 FLUID CONTROL DEVICES AND METHODS OF USING THE SAME Magnolia Medical Technologies, Inc. KREMER, MATTHEW 3791 §112Other Final Rejection 63d Pending Feb 02, 2022
17591309 USE OF PCBP1 TO GENERATE INDUCED PLURIPOTENT STEM CELLS WHILE INHIBITING ONCOGENESIS Ibex Biosciences, LLC RYAN, DOUGLAS CHARLES 1635 §103§112 Final Rejection — Pending Feb 02, 2022
17630477 ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOF Cttq-Akeso (Shanghai) Biomed. Tech. Co., Ltd. PETERS, ALEC JON 1641 §102§103§112DP Non-Final OA — Pending Jan 26, 2022
17630467 ANTI-CTLA4-ANTI-PD-1 BISPECIFIC ANTIBODY AND USES THEREOF Akeso Pharmaceuticals, Inc. LUNDE, GRACE HENRY 1641 §102§103§112DP Non-Final OA — Pending Jan 26, 2022
17579470 Methods and kits for diagnosis of cancer and prediction of therapeutic value Cornell University CRAIG, KAILA ANGELIQUE 1618 §103 Final Rejection 78d overdue Pending Jan 19, 2022
17597259 HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS Portland Technology Holdings LLC ALAM, AYAAN A 1611 §103DP Non-Final OA — Pending Dec 30, 2021
17554927 Methods of treating amyloid-beta peptide diseases ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE BAKSHI, PANCHAM 1623 §103§112 Non-Final OA — Pending Dec 17, 2021
17644923 NOVEL CANCER ANTIGENS AND METHODS The Francis Crick Institute Limited LU, CHENG 1642 §102§103 Non-Final OA 20d Pending Dec 17, 2021
17644938 NOVEL CANCER ANTIGENS AND METHODS Enara Bio Limited VAN DRUFF, SYDNEY 1643 §103§112DP Non-Final OA — Pending Dec 17, 2021
17616382 TGF-BETA VACCINE Io Biotech Aps HOPKINS, SAMANTHA LAKE 1641 §101§102§103§112 Non-Final OA — Pending Dec 03, 2021
17606370 USE OF CANNABIDIOL IN THE TREATMENT OF TUBEROUS SCLEROSIS COMPLEX Gw Research Limited TRAN, ERIC 1629 §103§112 Non-Final OA — Pending Oct 25, 2021
17602183 PROTEIN BINDERS FOR IRHOM2 Scirhom GmbH SHUPE, ELIZABETH A 1643 §112DP Non-Final OA — Pending Oct 07, 2021
17491079 SYSTEMS, DEVICES, AND METHODS FOR NON-INVASIVE CARDIAC MONITORING Vivalnk, Inc. XU, JUSTIN 3791 §101 Final Rejection 100d overdue Pending Sep 30, 2021
17482858 COFFEE ROASTING SYSTEM WITH ROASTING AND COOLING SUBSYSTEMS Bellwether Coffee Co. TRAN, TIFFANY T 3761 §103 Non-Final OA 80d overdue Pending Sep 23, 2021
17478112 COMPOSITIONS AND METHODS FOR TREATING NONINFECTIOUS UVEITIS Clearside Biomedical, Inc. HUI, SAN MING R 1627 §103 Non-Final OA — Pending Sep 17, 2021
17593403 METHODS FOR THE DIAGNOSIS OF LUNG CANCER Peptomyc, S.L. CRAIG, KAILA ANGELIQUE 1618 §103 Non-Final OA — Pending Sep 17, 2021
17593408 COMBINATION THERAPY WITH OMOMYC AND AN ANTIBODY BINDING PD-1 OR CTLA-4 FOR THE TREATMENT OF CANCER Peptomyc, S.L. HOLTZMAN, KATHERINE ANN 1646 §103DP Non-Final OA — Pending Sep 17, 2021
17438303 MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS Surrozen Operating, Inc. LI, RUIXIANG 1674 §112 Non-Final OA — Pending Sep 10, 2021
17416810 NOROVIRUS VACCINE FORMULATIONS AND METHODS Takeda Vaccines, Inc. SIFFORD, JEFFREY MARK 1671 §102§103§112Other Final Rejection 46d overdue Pending Jun 21, 2021
17348651 Devices and Methods For Application Of Microneedle Arrays Using Radial And Axial Accelerations Biolinq Incorporated HOFFPAUIR, ANDREW ELI 3791 §103 Final Rejection — Pending Jun 15, 2021
17413786 IL-15 COMPOSITIONS AND METHODS OF USE THEREOF Proviva Therapeutics (Hong Kong) Limited BERHANE, SELAM 1675 §112 Final Rejection — Pending Jun 14, 2021
17203464 CONNECTION QUALITY ASSESSMENT FOR EEG ELECTRODE ARRAYS Ceribell, Inc. PORTER, JR, GARY A 3796 §101§103§112Other Final Rejection 81d overdue Pending Mar 16, 2021
17199233 METHODS AND SYSTEMS FOR FACILITATING FORECASTING OF IN-SITU ENVIRONMENTAL CONDITIONS USING NONLINEAR ARTIFICIAL NEURAL NETWORKS-BASED MODELS Benchmark Labs, Inc. TAN, DAVID H 2145 §101§103 Final Rejection — Pending Mar 11, 2021
17184431 HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6 Tes Pharma S.r.l. SHTERENGARTS, SAMANTHA L 1623 §102§112 Final Rejection 28d Pending Feb 24, 2021
17149493 DEVICES AND METHODS FOR POSITIONING A GUIDEWIRE Ancora Heart, Inc. VOKES, KATHLEEN PAIGE 3783 §102§103§112 Final Rejection — Pending Jan 14, 2021
17052079 TACI-FC FUSION PROTEINS AND USES THEREOF Remegen Co., Ltd. FISCHER, JOSEPH 1658 §103DP Final Rejection — Pending Oct 30, 2020
17083078 SYSTEMS AND METHODS FOR PROCESSING SONIFIED BRAIN SIGNALS Ceribell, Inc. TU, AURELIE H 3791 §101 Non-Final OA 79d overdue Pending Oct 28, 2020
17019042 SYSTEMS, DEVICES, AND METHODS FOR FORMING AN ANASTOMOSIS Alleviant Medical, Inc. DELLA, JAYMI E 3794 §103§112 Final Rejection 100d overdue Pending Sep 11, 2020
16935005 USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY Gw Research Limited BAEK, BONG-SOOK 1611 §103DP Final Rejection — Pending Jul 21, 2020
16853384 ANCHOR DEPLOYMENT DEVICES AND RELATED METHODS Ancora Heart, Inc. LAUER, CHRISTINA C 3771 §103 Final Rejection — Pending Apr 20, 2020
16652867 VECTORS WITH PROMOTER AND ENHANCER COMBINATIONS FOR TREATING PHENYLKETONURIA American Gene Technologies International Inc. PARKIN, JEFFREY S 1671 §112 Non-Final OA — Pending Apr 01, 2020
15640033 CANNABINOID FORMULATIONS Jazz Pharmaceuticals Research UK Limited MATTISON, LORI K 1619 §103§112DP Non-Final OA — Pending Jun 30, 2017
14814383 SYSTEMS AND METHODS FOR CARDIAC REMODELING Ancora Heart, Inc. ALEMAN, SARAH WEBB 3774 §103 Final Rejection 46d overdue Pending Jul 30, 2015

Managing Cooley LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month